Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for SP4_PML
Z-value: 4.21
Motif logo
Transcription factors associated with SP4_PML
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SP4
|
ENSG00000105866.9 | Sp4 transcription factor |
|
PML
|
ENSG00000140464.15 | PML nuclear body scaffold |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SP4 | hg19_v2_chr7_+_21467642_21467671 | 0.71 | 4.8e-04 | Click! |
| PML | hg19_v2_chr15_+_74287118_74287144 | -0.53 | 1.6e-02 | Click! |
Activity profile of SP4_PML motif
Sorted Z-values of SP4_PML motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr2_+_54684327 | 13.74 |
ENST00000389980.3
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
| chr14_+_100259712 | 12.19 |
ENST00000556714.1
|
EML1
|
echinoderm microtubule associated protein like 1 |
| chr18_+_33161698 | 11.86 |
ENST00000591924.1
|
GALNT1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1) |
| chr3_-_194207388 | 11.65 |
ENST00000457986.1
|
ATP13A3
|
ATPase type 13A3 |
| chr9_+_116638630 | 11.33 |
ENST00000452710.1
ENST00000374124.4 |
ZNF618
|
zinc finger protein 618 |
| chr18_-_3013307 | 10.81 |
ENST00000584294.1
|
LPIN2
|
lipin 2 |
| chr3_-_27525826 | 9.93 |
ENST00000454389.1
ENST00000440156.1 ENST00000437179.1 ENST00000446700.1 ENST00000455077.1 ENST00000435667.2 ENST00000388777.4 ENST00000425128.2 |
SLC4A7
|
solute carrier family 4, sodium bicarbonate cotransporter, member 7 |
| chr7_-_131241361 | 9.91 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
| chr8_-_142318398 | 9.50 |
ENST00000520137.1
|
SLC45A4
|
solute carrier family 45, member 4 |
| chr6_+_163835669 | 9.35 |
ENST00000453779.2
ENST00000275262.7 ENST00000392127.2 ENST00000361752.3 |
QKI
|
QKI, KH domain containing, RNA binding |
| chr22_-_43583079 | 9.20 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr8_+_21906433 | 8.99 |
ENST00000522148.1
|
DMTN
|
dematin actin binding protein |
| chr2_+_235860690 | 8.97 |
ENST00000416021.1
|
SH3BP4
|
SH3-domain binding protein 4 |
| chr12_-_125052010 | 8.96 |
ENST00000458234.1
|
NCOR2
|
nuclear receptor corepressor 2 |
| chr11_+_48002279 | 8.69 |
ENST00000534219.1
ENST00000527952.1 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr13_-_22033392 | 8.64 |
ENST00000320220.9
ENST00000415724.1 ENST00000422251.1 ENST00000382466.3 ENST00000542645.1 ENST00000400590.3 |
ZDHHC20
|
zinc finger, DHHC-type containing 20 |
| chr2_+_30455016 | 8.48 |
ENST00000401506.1
ENST00000407930.2 |
LBH
|
limb bud and heart development |
| chr12_-_105352047 | 8.32 |
ENST00000432951.1
ENST00000415674.1 ENST00000424946.1 |
SLC41A2
|
solute carrier family 41 (magnesium transporter), member 2 |
| chr9_-_113800705 | 8.31 |
ENST00000441240.1
|
LPAR1
|
lysophosphatidic acid receptor 1 |
| chr1_-_31381528 | 8.21 |
ENST00000339394.6
|
SDC3
|
syndecan 3 |
| chr10_-_977564 | 8.15 |
ENST00000406525.2
|
LARP4B
|
La ribonucleoprotein domain family, member 4B |
| chr13_+_114239588 | 8.06 |
ENST00000544902.1
ENST00000408980.2 ENST00000453989.1 |
TFDP1
|
transcription factor Dp-1 |
| chr22_-_42739533 | 8.03 |
ENST00000515426.1
|
TCF20
|
transcription factor 20 (AR1) |
| chr9_+_137218362 | 7.96 |
ENST00000481739.1
|
RXRA
|
retinoid X receptor, alpha |
| chr2_+_109150850 | 7.78 |
ENST00000544547.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
| chr2_+_74212073 | 7.69 |
ENST00000441217.1
|
AC073046.25
|
AC073046.25 |
| chr2_-_37551846 | 7.69 |
ENST00000443187.1
|
PRKD3
|
protein kinase D3 |
| chr14_+_100259666 | 7.52 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
| chr7_-_108097144 | 7.40 |
ENST00000418239.1
|
NRCAM
|
neuronal cell adhesion molecule |
| chr16_+_50280020 | 7.37 |
ENST00000564965.1
|
ADCY7
|
adenylate cyclase 7 |
| chr5_-_79950371 | 7.28 |
ENST00000511032.1
ENST00000504396.1 ENST00000505337.1 |
DHFR
|
dihydrofolate reductase |
| chr13_-_99738867 | 7.16 |
ENST00000427887.1
|
DOCK9
|
dedicator of cytokinesis 9 |
| chr1_+_233463507 | 7.15 |
ENST00000366623.3
ENST00000366624.3 |
MLK4
|
Mitogen-activated protein kinase kinase kinase MLK4 |
| chr8_-_19614810 | 7.10 |
ENST00000524213.1
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
| chr5_+_154135029 | 7.10 |
ENST00000518297.1
|
LARP1
|
La ribonucleoprotein domain family, member 1 |
| chr2_+_109150887 | 7.08 |
ENST00000428064.1
|
LIMS1
|
LIM and senescent cell antigen-like domains 1 |
| chr20_-_47444420 | 7.04 |
ENST00000371941.3
ENST00000396220.1 |
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
| chr11_+_44748361 | 7.01 |
ENST00000533202.1
ENST00000533080.1 ENST00000520358.2 ENST00000520999.2 |
TSPAN18
|
tetraspanin 18 |
| chr12_-_121734489 | 7.00 |
ENST00000412367.2
ENST00000402834.4 ENST00000404169.3 |
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta |
| chr17_+_16945820 | 6.98 |
ENST00000577514.1
|
MPRIP
|
myosin phosphatase Rho interacting protein |
| chr22_-_22221658 | 6.97 |
ENST00000544786.1
|
MAPK1
|
mitogen-activated protein kinase 1 |
| chrX_+_9433289 | 6.97 |
ENST00000422314.1
|
TBL1X
|
transducin (beta)-like 1X-linked |
| chr3_-_176915215 | 6.94 |
ENST00000457928.2
ENST00000422442.1 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr1_-_247095236 | 6.90 |
ENST00000478568.1
|
AHCTF1
|
AT hook containing transcription factor 1 |
| chr20_+_33814457 | 6.90 |
ENST00000246186.6
|
MMP24
|
matrix metallopeptidase 24 (membrane-inserted) |
| chr15_-_30261066 | 6.87 |
ENST00000558447.1
|
TJP1
|
tight junction protein 1 |
| chr9_-_115095851 | 6.84 |
ENST00000343327.2
|
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr17_-_16256718 | 6.83 |
ENST00000476243.1
ENST00000299736.4 |
CENPV
|
centromere protein V |
| chr4_-_6565315 | 6.83 |
ENST00000506140.1
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr14_-_105714771 | 6.83 |
ENST00000550375.1
|
BRF1
|
BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit |
| chr6_-_18264706 | 6.76 |
ENST00000244776.7
ENST00000503715.1 |
DEK
|
DEK oncogene |
| chr2_+_234263120 | 6.74 |
ENST00000264057.2
ENST00000427930.1 |
DGKD
|
diacylglycerol kinase, delta 130kDa |
| chr21_+_38071430 | 6.73 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
| chr2_-_107503558 | 6.73 |
ENST00000361686.4
ENST00000409087.3 |
ST6GAL2
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 |
| chr9_+_116638562 | 6.73 |
ENST00000374126.5
ENST00000288466.7 |
ZNF618
|
zinc finger protein 618 |
| chr10_+_22610876 | 6.72 |
ENST00000442508.1
|
BMI1
|
BMI1 polycomb ring finger oncogene |
| chr9_-_114245938 | 6.72 |
ENST00000602447.1
|
KIAA0368
|
KIAA0368 |
| chr8_+_27491381 | 6.67 |
ENST00000337221.4
|
SCARA3
|
scavenger receptor class A, member 3 |
| chr22_-_44894178 | 6.67 |
ENST00000341255.3
|
LDOC1L
|
leucine zipper, down-regulated in cancer 1-like |
| chr18_+_77867177 | 6.63 |
ENST00000560752.1
|
ADNP2
|
ADNP homeobox 2 |
| chr17_+_1733251 | 6.62 |
ENST00000570451.1
|
RPA1
|
replication protein A1, 70kDa |
| chr7_-_108096822 | 6.61 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr18_-_9614251 | 6.56 |
ENST00000581835.1
ENST00000581250.1 |
PPP4R1
|
protein phosphatase 4, regulatory subunit 1 |
| chr7_+_156931889 | 6.56 |
ENST00000389103.4
|
UBE3C
|
ubiquitin protein ligase E3C |
| chr5_+_172261311 | 6.53 |
ENST00000520326.1
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
| chr3_-_98619999 | 6.49 |
ENST00000449482.1
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
| chr15_+_27112296 | 6.49 |
ENST00000554038.1
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
| chr19_-_1568057 | 6.45 |
ENST00000402693.4
ENST00000388824.6 |
MEX3D
|
mex-3 RNA binding family member D |
| chr7_-_108096765 | 6.40 |
ENST00000379024.4
ENST00000351718.4 |
NRCAM
|
neuronal cell adhesion molecule |
| chr8_-_117886612 | 6.36 |
ENST00000520992.1
|
RAD21
|
RAD21 homolog (S. pombe) |
| chr15_+_73344911 | 6.34 |
ENST00000560262.1
ENST00000558964.1 |
NEO1
|
neogenin 1 |
| chr1_+_230203010 | 6.31 |
ENST00000541865.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
| chr2_+_11295624 | 6.31 |
ENST00000402361.1
ENST00000428481.1 |
PQLC3
|
PQ loop repeat containing 3 |
| chr6_+_149638876 | 6.30 |
ENST00000392282.1
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 |
| chr9_-_134615326 | 6.28 |
ENST00000438647.1
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1 |
| chr19_-_6424283 | 6.28 |
ENST00000595258.1
ENST00000595548.1 |
KHSRP
|
KH-type splicing regulatory protein |
| chr5_+_172261356 | 6.26 |
ENST00000523291.1
|
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
| chr14_-_53417732 | 6.26 |
ENST00000399304.3
ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2
|
fermitin family member 2 |
| chr16_-_58034357 | 6.22 |
ENST00000562909.1
|
ZNF319
|
zinc finger protein 319 |
| chr12_-_90103077 | 6.17 |
ENST00000551310.1
|
ATP2B1
|
ATPase, Ca++ transporting, plasma membrane 1 |
| chr4_+_37978891 | 6.14 |
ENST00000446803.2
|
TBC1D1
|
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
| chr3_-_176915036 | 6.14 |
ENST00000427349.1
ENST00000352800.5 |
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1 |
| chr10_-_79397391 | 6.10 |
ENST00000286628.8
ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr9_+_127539425 | 6.09 |
ENST00000331715.9
|
OLFML2A
|
olfactomedin-like 2A |
| chr8_-_131028782 | 6.06 |
ENST00000519020.1
|
FAM49B
|
family with sequence similarity 49, member B |
| chr8_-_117886732 | 6.05 |
ENST00000517485.1
|
RAD21
|
RAD21 homolog (S. pombe) |
| chr5_+_149865377 | 6.02 |
ENST00000522491.1
|
NDST1
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
| chr3_+_170075436 | 6.00 |
ENST00000476188.1
ENST00000259119.4 ENST00000426052.2 |
SKIL
|
SKI-like oncogene |
| chr8_-_117886563 | 5.99 |
ENST00000519837.1
ENST00000522699.1 |
RAD21
|
RAD21 homolog (S. pombe) |
| chr2_-_233792837 | 5.99 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr9_-_138987115 | 5.98 |
ENST00000277554.2
|
NACC2
|
NACC family member 2, BEN and BTB (POZ) domain containing |
| chr17_-_78450398 | 5.96 |
ENST00000306773.4
|
NPTX1
|
neuronal pentraxin I |
| chrX_-_2418596 | 5.95 |
ENST00000381218.3
|
ZBED1
|
zinc finger, BED-type containing 1 |
| chr2_+_30454390 | 5.95 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
| chr4_+_1873100 | 5.94 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
| chr17_-_74236382 | 5.94 |
ENST00000592271.1
ENST00000319945.6 ENST00000269391.6 |
RNF157
|
ring finger protein 157 |
| chr17_+_64298944 | 5.91 |
ENST00000413366.3
|
PRKCA
|
protein kinase C, alpha |
| chr9_+_97767235 | 5.91 |
ENST00000445181.1
|
C9orf3
|
chromosome 9 open reading frame 3 |
| chr9_+_96214166 | 5.90 |
ENST00000375389.3
ENST00000333936.5 ENST00000340893.4 |
FAM120A
|
family with sequence similarity 120A |
| chr7_-_2883650 | 5.90 |
ENST00000544127.1
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12 |
| chr1_-_229694406 | 5.90 |
ENST00000344517.4
|
ABCB10
|
ATP-binding cassette, sub-family B (MDR/TAP), member 10 |
| chr2_+_191513587 | 5.89 |
ENST00000416973.1
ENST00000426601.1 |
NAB1
|
NGFI-A binding protein 1 (EGR1 binding protein 1) |
| chr2_-_174828892 | 5.89 |
ENST00000418194.2
|
SP3
|
Sp3 transcription factor |
| chr10_+_22610124 | 5.88 |
ENST00000376663.3
|
BMI1
|
BMI1 polycomb ring finger oncogene |
| chr7_+_55086703 | 5.87 |
ENST00000455089.1
ENST00000342916.3 ENST00000344576.2 ENST00000420316.2 |
EGFR
|
epidermal growth factor receptor |
| chr8_+_98788003 | 5.85 |
ENST00000521545.2
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
| chr11_+_13690249 | 5.85 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
| chr1_+_166808667 | 5.83 |
ENST00000537173.1
ENST00000536514.1 ENST00000449930.1 |
POGK
|
pogo transposable element with KRAB domain |
| chr10_+_28822636 | 5.81 |
ENST00000442148.1
ENST00000448193.1 |
WAC
|
WW domain containing adaptor with coiled-coil |
| chr2_+_25264933 | 5.81 |
ENST00000401432.3
ENST00000403714.3 |
EFR3B
|
EFR3 homolog B (S. cerevisiae) |
| chr10_-_14646388 | 5.80 |
ENST00000468747.1
ENST00000378467.4 |
FAM107B
|
family with sequence similarity 107, member B |
| chr5_+_10564432 | 5.80 |
ENST00000296657.5
|
ANKRD33B
|
ankyrin repeat domain 33B |
| chr1_-_150946911 | 5.80 |
ENST00000457392.1
ENST00000421609.1 |
CERS2
|
ceramide synthase 2 |
| chr18_+_20715416 | 5.74 |
ENST00000580153.1
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
| chr7_-_50861129 | 5.74 |
ENST00000439044.1
ENST00000402497.1 ENST00000335866.3 |
GRB10
|
growth factor receptor-bound protein 10 |
| chr11_+_34073872 | 5.71 |
ENST00000530820.1
|
CAPRIN1
|
cell cycle associated protein 1 |
| chr4_+_174089951 | 5.68 |
ENST00000512285.1
|
GALNT7
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7) |
| chr4_+_1873155 | 5.68 |
ENST00000507820.1
ENST00000514045.1 |
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
| chr20_-_43438912 | 5.67 |
ENST00000541604.2
ENST00000372851.3 |
RIMS4
|
regulating synaptic membrane exocytosis 4 |
| chr2_-_11484710 | 5.67 |
ENST00000315872.6
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2 |
| chr5_+_61602236 | 5.64 |
ENST00000514082.1
ENST00000407818.3 |
KIF2A
|
kinesin heavy chain member 2A |
| chr7_-_156685841 | 5.64 |
ENST00000354505.4
ENST00000540390.1 |
LMBR1
|
limb development membrane protein 1 |
| chr15_+_27112380 | 5.59 |
ENST00000554596.1
|
GABRA5
|
gamma-aminobutyric acid (GABA) A receptor, alpha 5 |
| chr7_-_32931623 | 5.59 |
ENST00000452926.1
|
KBTBD2
|
kelch repeat and BTB (POZ) domain containing 2 |
| chr1_-_212003556 | 5.59 |
ENST00000366996.1
|
LPGAT1
|
lysophosphatidylglycerol acyltransferase 1 |
| chr5_+_154135453 | 5.55 |
ENST00000517616.1
ENST00000518892.1 |
LARP1
|
La ribonucleoprotein domain family, member 1 |
| chr13_-_102068706 | 5.55 |
ENST00000251127.6
|
NALCN
|
sodium leak channel, non-selective |
| chr17_-_42907564 | 5.54 |
ENST00000592524.1
|
GJC1
|
gap junction protein, gamma 1, 45kDa |
| chr4_+_103422499 | 5.53 |
ENST00000511926.1
ENST00000507079.1 |
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
| chr17_-_56065540 | 5.52 |
ENST00000583932.1
|
VEZF1
|
vascular endothelial zinc finger 1 |
| chr7_-_105925367 | 5.52 |
ENST00000354289.4
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
| chr2_-_25142708 | 5.51 |
ENST00000260600.5
ENST00000435135.1 |
ADCY3
|
adenylate cyclase 3 |
| chr20_+_34680595 | 5.50 |
ENST00000406771.2
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr13_-_77601327 | 5.50 |
ENST00000417323.1
|
FBXL3
|
F-box and leucine-rich repeat protein 3 |
| chr3_-_33482002 | 5.50 |
ENST00000283628.5
ENST00000456378.1 |
UBP1
|
upstream binding protein 1 (LBP-1a) |
| chr8_+_21777243 | 5.48 |
ENST00000521303.1
|
XPO7
|
exportin 7 |
| chr11_+_48002076 | 5.47 |
ENST00000418331.2
ENST00000440289.2 |
PTPRJ
|
protein tyrosine phosphatase, receptor type, J |
| chr15_-_27018175 | 5.46 |
ENST00000311550.5
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr14_-_39572345 | 5.44 |
ENST00000548032.2
ENST00000556092.1 ENST00000557280.1 ENST00000545328.2 ENST00000553970.1 |
SEC23A
|
Sec23 homolog A (S. cerevisiae) |
| chr5_-_142783694 | 5.43 |
ENST00000394466.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
| chr16_-_54963026 | 5.42 |
ENST00000560208.1
ENST00000557792.1 |
CRNDE
|
colorectal neoplasia differentially expressed (non-protein coding) |
| chr4_-_6474173 | 5.41 |
ENST00000382599.4
|
PPP2R2C
|
protein phosphatase 2, regulatory subunit B, gamma |
| chr2_-_242211359 | 5.40 |
ENST00000444092.1
|
HDLBP
|
high density lipoprotein binding protein |
| chr8_-_131028660 | 5.38 |
ENST00000401979.2
ENST00000517654.1 ENST00000522361.1 ENST00000518167.1 |
FAM49B
|
family with sequence similarity 49, member B |
| chr12_-_47473425 | 5.37 |
ENST00000550413.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr3_-_15901278 | 5.36 |
ENST00000399451.2
|
ANKRD28
|
ankyrin repeat domain 28 |
| chr19_+_3366547 | 5.36 |
ENST00000341919.3
ENST00000590282.1 ENST00000443272.2 |
NFIC
|
nuclear factor I/C (CCAAT-binding transcription factor) |
| chr14_+_31343951 | 5.33 |
ENST00000556908.1
ENST00000555881.1 ENST00000460581.2 |
COCH
|
cochlin |
| chr4_+_6784358 | 5.33 |
ENST00000508423.1
|
KIAA0232
|
KIAA0232 |
| chr1_-_53793725 | 5.33 |
ENST00000371454.2
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
| chr18_+_9334786 | 5.33 |
ENST00000581641.1
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1 |
| chr8_+_98788057 | 5.33 |
ENST00000517924.1
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta |
| chr7_-_27239703 | 5.31 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
| chr17_+_77751931 | 5.31 |
ENST00000310942.4
ENST00000269399.5 |
CBX2
|
chromobox homolog 2 |
| chr3_+_141121164 | 5.30 |
ENST00000510338.1
ENST00000504673.1 |
ZBTB38
|
zinc finger and BTB domain containing 38 |
| chrX_-_135056106 | 5.29 |
ENST00000433339.2
|
MMGT1
|
membrane magnesium transporter 1 |
| chr11_+_12696102 | 5.27 |
ENST00000527636.1
ENST00000527376.1 |
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
| chr1_-_150947299 | 5.26 |
ENST00000361419.5
|
CERS2
|
ceramide synthase 2 |
| chr6_-_86353510 | 5.25 |
ENST00000444272.1
|
SYNCRIP
|
synaptotagmin binding, cytoplasmic RNA interacting protein |
| chr2_+_223725723 | 5.23 |
ENST00000535678.1
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3 |
| chr17_-_20946710 | 5.22 |
ENST00000584538.1
|
USP22
|
ubiquitin specific peptidase 22 |
| chr14_+_103243813 | 5.21 |
ENST00000560371.1
ENST00000347662.4 ENST00000392745.2 ENST00000539721.1 ENST00000560463.1 |
TRAF3
|
TNF receptor-associated factor 3 |
| chr6_+_17393888 | 5.17 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr8_+_41435934 | 5.17 |
ENST00000520223.1
|
AGPAT6
|
1-acylglycerol-3-phosphate O-acyltransferase 6 |
| chr2_-_230786378 | 5.17 |
ENST00000430954.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
| chr2_-_9771075 | 5.17 |
ENST00000446619.1
ENST00000238081.3 |
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta |
| chr18_+_8705588 | 5.16 |
ENST00000306329.11
|
SOGA2
|
SOGA family member 2 |
| chr8_+_90914859 | 5.14 |
ENST00000520659.1
|
OSGIN2
|
oxidative stress induced growth inhibitor family member 2 |
| chr8_+_38614778 | 5.14 |
ENST00000521050.1
ENST00000522904.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
| chrX_-_20284733 | 5.14 |
ENST00000438357.1
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
| chr10_-_79397740 | 5.13 |
ENST00000372440.1
ENST00000480683.1 |
KCNMA1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
| chr17_+_78234625 | 5.13 |
ENST00000508628.2
ENST00000582970.1 ENST00000456466.1 ENST00000319921.4 |
RNF213
|
ring finger protein 213 |
| chr18_+_56530692 | 5.10 |
ENST00000588601.1
|
ZNF532
|
zinc finger protein 532 |
| chr19_-_4065730 | 5.09 |
ENST00000601588.1
|
ZBTB7A
|
zinc finger and BTB domain containing 7A |
| chr12_-_47473557 | 5.08 |
ENST00000321382.3
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr10_+_128593978 | 5.08 |
ENST00000280333.6
|
DOCK1
|
dedicator of cytokinesis 1 |
| chr18_+_11981547 | 5.07 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
| chr2_-_128145498 | 5.06 |
ENST00000409179.2
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2 |
| chr8_-_99837856 | 5.06 |
ENST00000518165.1
ENST00000419617.2 |
STK3
|
serine/threonine kinase 3 |
| chr15_+_78857870 | 5.02 |
ENST00000559554.1
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal) |
| chr10_-_15413035 | 5.01 |
ENST00000378116.4
ENST00000455654.1 |
FAM171A1
|
family with sequence similarity 171, member A1 |
| chr17_-_62658186 | 5.01 |
ENST00000262435.9
|
SMURF2
|
SMAD specific E3 ubiquitin protein ligase 2 |
| chr11_+_8040739 | 5.00 |
ENST00000534099.1
|
TUB
|
tubby bipartite transcription factor |
| chr9_+_128509663 | 5.00 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr14_+_31343747 | 4.99 |
ENST00000216361.4
ENST00000396618.3 ENST00000475087.1 |
COCH
|
cochlin |
| chr6_+_17393839 | 4.99 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr15_+_101459420 | 4.98 |
ENST00000388948.3
ENST00000284395.5 ENST00000534045.1 ENST00000532029.2 |
LRRK1
|
leucine-rich repeat kinase 1 |
| chr12_-_47473642 | 4.98 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr8_+_26149274 | 4.97 |
ENST00000522535.1
|
PPP2R2A
|
protein phosphatase 2, regulatory subunit B, alpha |
| chr15_+_69591235 | 4.96 |
ENST00000395407.2
ENST00000558684.1 |
PAQR5
|
progestin and adipoQ receptor family member V |
| chr9_-_136933092 | 4.95 |
ENST00000357885.2
|
BRD3
|
bromodomain containing 3 |
| chr12_+_96588279 | 4.95 |
ENST00000552142.1
|
ELK3
|
ELK3, ETS-domain protein (SRF accessory protein 2) |
| chr17_-_655278 | 4.94 |
ENST00000574958.1
ENST00000437269.1 ENST00000573482.1 |
GEMIN4
|
gem (nuclear organelle) associated protein 4 |
| chr17_-_935036 | 4.94 |
ENST00000572441.1
ENST00000543210.2 |
ABR
|
active BCR-related |
| chr8_+_98881268 | 4.93 |
ENST00000254898.5
ENST00000524308.1 ENST00000522025.2 |
MATN2
|
matrilin 2 |
| chr7_+_6655225 | 4.93 |
ENST00000457543.3
|
ZNF853
|
zinc finger protein 853 |
| chr18_-_9614863 | 4.93 |
ENST00000584074.1
|
PPP4R1
|
protein phosphatase 4, regulatory subunit 1 |
| chr19_-_2721336 | 4.90 |
ENST00000588128.1
|
DIRAS1
|
DIRAS family, GTP-binding RAS-like 1 |
| chr2_-_175870085 | 4.88 |
ENST00000409156.3
|
CHN1
|
chimerin 1 |
| chr7_-_55640141 | 4.88 |
ENST00000452832.1
|
VOPP1
|
vesicular, overexpressed in cancer, prosurvival protein 1 |
Network of associatons between targets according to the STRING database.
First level regulatory network of SP4_PML
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 17.4 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 3.8 | 11.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 3.6 | 10.9 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 3.6 | 17.9 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 3.5 | 10.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 3.5 | 24.3 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 3.5 | 10.4 | GO:0007388 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
| 3.5 | 13.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 3.2 | 12.9 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 3.1 | 18.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 2.8 | 8.4 | GO:0030522 | intracellular receptor signaling pathway(GO:0030522) |
| 2.8 | 8.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 2.7 | 8.2 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 2.7 | 8.0 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 2.7 | 10.6 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 2.7 | 8.0 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 2.6 | 15.4 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 2.6 | 7.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 2.5 | 7.6 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
| 2.5 | 7.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 2.4 | 12.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.4 | 14.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 2.4 | 7.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 2.4 | 7.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 2.3 | 11.7 | GO:0072053 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 2.3 | 9.3 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 2.3 | 9.1 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 2.3 | 6.8 | GO:0021503 | neural fold bending(GO:0021503) |
| 2.2 | 4.5 | GO:1903826 | basic amino acid transport(GO:0015802) arginine transport(GO:0015809) arginine transmembrane transport(GO:1903826) |
| 2.2 | 17.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 2.2 | 6.6 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 2.2 | 26.3 | GO:0034465 | response to carbon monoxide(GO:0034465) |
| 2.1 | 6.4 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 2.1 | 6.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
| 2.1 | 6.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 2.1 | 8.4 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 2.1 | 12.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 2.0 | 6.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 2.0 | 6.1 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 2.0 | 10.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 2.0 | 10.1 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 2.0 | 8.0 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 2.0 | 11.9 | GO:0070541 | response to platinum ion(GO:0070541) |
| 2.0 | 3.9 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 1.9 | 1.9 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 1.9 | 7.6 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 1.8 | 3.6 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.8 | 7.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 1.8 | 7.1 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 1.8 | 7.1 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 1.7 | 7.0 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 1.7 | 5.2 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.7 | 10.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.7 | 10.2 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 1.7 | 10.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 1.7 | 13.5 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 1.7 | 6.7 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 1.6 | 4.9 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 1.6 | 4.9 | GO:0051795 | positive regulation of catagen(GO:0051795) |
| 1.6 | 4.8 | GO:0031106 | septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.6 | 14.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 1.6 | 8.0 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.6 | 20.6 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 1.6 | 1.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.6 | 4.7 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 1.6 | 23.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 1.6 | 10.9 | GO:0071486 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.5 | 4.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 1.5 | 4.6 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 1.5 | 7.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.5 | 7.6 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 1.5 | 4.6 | GO:0003250 | cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) |
| 1.5 | 4.5 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.5 | 1.5 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 1.5 | 1.5 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 1.5 | 5.9 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 1.5 | 1.5 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 1.5 | 4.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
| 1.5 | 4.4 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
| 1.5 | 1.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 1.4 | 5.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 1.4 | 5.7 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.4 | 4.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 1.4 | 5.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.4 | 5.6 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.4 | 8.4 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.4 | 5.6 | GO:0016598 | protein arginylation(GO:0016598) |
| 1.4 | 13.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 1.4 | 12.4 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 1.4 | 5.5 | GO:0060032 | notochord regression(GO:0060032) |
| 1.4 | 8.2 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
| 1.4 | 32.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 1.4 | 2.7 | GO:0061198 | fungiform papilla formation(GO:0061198) |
| 1.3 | 20.0 | GO:0060613 | fat pad development(GO:0060613) |
| 1.3 | 8.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.3 | 1.3 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 1.3 | 9.3 | GO:0051414 | response to cortisol(GO:0051414) |
| 1.3 | 2.6 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 1.3 | 3.9 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 1.3 | 3.9 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 1.3 | 5.2 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.3 | 3.9 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 1.3 | 1.3 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) |
| 1.3 | 5.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.3 | 5.1 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.3 | 9.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.3 | 1.3 | GO:1903052 | positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
| 1.3 | 7.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 1.3 | 2.6 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 1.3 | 5.1 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 1.3 | 6.4 | GO:0015862 | uridine transport(GO:0015862) |
| 1.3 | 5.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.3 | 6.4 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
| 1.3 | 3.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
| 1.3 | 7.6 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 1.3 | 15.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.3 | 6.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.3 | 5.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 1.3 | 5.0 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.2 | 3.7 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 1.2 | 3.7 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 1.2 | 12.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 1.2 | 4.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.2 | 3.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 1.2 | 2.4 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 1.2 | 9.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 1.2 | 8.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.2 | 4.7 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 1.2 | 8.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 1.2 | 18.9 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.2 | 2.3 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.2 | 2.3 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.2 | 3.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 1.2 | 6.9 | GO:1904209 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 1.1 | 6.9 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
| 1.1 | 7.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 1.1 | 3.4 | GO:0060623 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) regulation of chromosome condensation(GO:0060623) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
| 1.1 | 5.7 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 1.1 | 22.6 | GO:0060242 | contact inhibition(GO:0060242) |
| 1.1 | 10.1 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 1.1 | 4.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 1.1 | 3.4 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
| 1.1 | 6.7 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 1.1 | 3.4 | GO:0070781 | response to biotin(GO:0070781) |
| 1.1 | 5.6 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 1.1 | 25.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 1.1 | 3.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 1.1 | 15.5 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.1 | 5.5 | GO:2001074 | thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 1.1 | 8.8 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 1.1 | 3.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
| 1.1 | 15.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 1.1 | 12.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 1.1 | 4.4 | GO:0035668 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 1.1 | 4.4 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.1 | 3.3 | GO:0003163 | sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 1.1 | 1.1 | GO:0014855 | striated muscle cell proliferation(GO:0014855) |
| 1.1 | 9.7 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 1.1 | 6.5 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 1.1 | 6.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.1 | 3.2 | GO:2001113 | negative regulation of hepatocyte growth factor receptor signaling pathway(GO:1902203) regulation of cellular response to hepatocyte growth factor stimulus(GO:2001112) negative regulation of cellular response to hepatocyte growth factor stimulus(GO:2001113) |
| 1.1 | 3.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 1.1 | 5.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 1.1 | 12.9 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 1.1 | 4.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 1.1 | 2.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 1.1 | 12.6 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 1.1 | 3.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 1.1 | 4.2 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 1.0 | 4.2 | GO:0006272 | leading strand elongation(GO:0006272) |
| 1.0 | 5.2 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 1.0 | 21.7 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.0 | 11.2 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.0 | 5.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 1.0 | 4.1 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
| 1.0 | 3.1 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 1.0 | 4.1 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 1.0 | 1.0 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
| 1.0 | 1.0 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 1.0 | 3.0 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 1.0 | 18.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 1.0 | 5.0 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 1.0 | 7.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 1.0 | 3.0 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 1.0 | 4.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 1.0 | 2.0 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
| 1.0 | 1.0 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 1.0 | 1.0 | GO:0035989 | tendon development(GO:0035989) tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.0 | 3.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.0 | 5.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.0 | 2.9 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) DNA demethylation of male pronucleus(GO:0044727) |
| 1.0 | 1.0 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.0 | 6.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 1.0 | 4.9 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 1.0 | 3.9 | GO:0048377 | lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 1.0 | 12.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 1.0 | 2.9 | GO:0022604 | regulation of cell morphogenesis(GO:0022604) |
| 1.0 | 2.9 | GO:0015709 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 1.0 | 4.8 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 1.0 | 3.9 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.0 | 7.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.0 | 2.9 | GO:0030047 | actin modification(GO:0030047) |
| 0.9 | 6.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.9 | 1.9 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.9 | 6.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.9 | 5.6 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.9 | 6.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.9 | 0.9 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.9 | 2.8 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.9 | 14.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.9 | 3.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.9 | 1.9 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.9 | 2.8 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.9 | 2.8 | GO:0006424 | glutamyl-tRNA aminoacylation(GO:0006424) |
| 0.9 | 11.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.9 | 8.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.9 | 2.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.9 | 6.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.9 | 1.8 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.9 | 3.6 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.9 | 0.9 | GO:0035922 | pulmonary valve formation(GO:0003193) foramen ovale closure(GO:0035922) |
| 0.9 | 3.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.9 | 1.8 | GO:0002691 | regulation of cellular extravasation(GO:0002691) |
| 0.9 | 0.9 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.9 | 8.0 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.9 | 1.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.9 | 0.9 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.9 | 5.3 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.9 | 5.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.9 | 4.4 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.9 | 3.5 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.9 | 4.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.9 | 8.7 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
| 0.9 | 7.9 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.9 | 0.9 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.9 | 6.1 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.9 | 0.9 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.9 | 5.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.9 | 1.7 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.9 | 0.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.9 | 12.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.9 | 3.4 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.9 | 8.5 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.8 | 12.7 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.8 | 11.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.8 | 2.5 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
| 0.8 | 6.7 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.8 | 2.5 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
| 0.8 | 4.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.8 | 7.4 | GO:0030242 | pexophagy(GO:0030242) |
| 0.8 | 2.5 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.8 | 4.9 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.8 | 2.5 | GO:0060733 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.8 | 1.6 | GO:2000177 | regulation of neural precursor cell proliferation(GO:2000177) |
| 0.8 | 1.6 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.8 | 9.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.8 | 2.5 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.8 | 5.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.8 | 4.1 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
| 0.8 | 3.2 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.8 | 9.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.8 | 2.4 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.8 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
| 0.8 | 5.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.8 | 0.8 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.8 | 5.6 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.8 | 3.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.8 | 3.2 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.8 | 3.2 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.8 | 4.8 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.8 | 8.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.8 | 11.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.8 | 2.4 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.8 | 2.4 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.8 | 5.5 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.8 | 3.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) N-terminal protein palmitoylation(GO:0006500) |
| 0.8 | 5.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.8 | 4.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.8 | 2.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 | 3.1 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
| 0.8 | 2.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.8 | 4.6 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.8 | 3.1 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.8 | 2.3 | GO:1903515 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
| 0.8 | 3.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.8 | 0.8 | GO:0021511 | spinal cord patterning(GO:0021511) |
| 0.8 | 11.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.8 | 9.2 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.8 | 3.1 | GO:0090135 | actin filament branching(GO:0090135) |
| 0.8 | 2.3 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 | 3.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.8 | 5.3 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.8 | 3.0 | GO:0090677 | metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 0.8 | 7.5 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.7 | 0.7 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 0.7 | 2.2 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.7 | 3.0 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.7 | 2.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.7 | 3.0 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.7 | 1.5 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.7 | 3.0 | GO:0010212 | response to ionizing radiation(GO:0010212) |
| 0.7 | 1.5 | GO:0070384 | Harderian gland development(GO:0070384) |
| 0.7 | 4.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.7 | 3.7 | GO:1901090 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.7 | 3.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.7 | 2.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.7 | 0.7 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.7 | 0.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.7 | 3.6 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.7 | 2.2 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.7 | 3.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 | 2.2 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.7 | 10.1 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 0.7 | 9.4 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.7 | 7.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.7 | 2.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
| 0.7 | 9.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.7 | 3.6 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.7 | 2.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.7 | 1.4 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.7 | 2.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.7 | 2.8 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.7 | 3.5 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.7 | 0.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.7 | 2.1 | GO:0021893 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.7 | 7.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.7 | 7.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.7 | 0.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.7 | 2.8 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.7 | 2.1 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.7 | 13.3 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.7 | 4.2 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.7 | 2.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.7 | 2.1 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 0.7 | 13.2 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
| 0.7 | 14.6 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
| 0.7 | 19.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.7 | 4.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.7 | 0.7 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.7 | 4.1 | GO:0051595 | response to methylglyoxal(GO:0051595) |
| 0.7 | 4.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 0.7 | 3.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.7 | 2.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.7 | 0.7 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 0.7 | 0.7 | GO:0019401 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.7 | 34.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.7 | 0.7 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.7 | 3.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.7 | 6.1 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.7 | 11.5 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.7 | 2.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.7 | 10.1 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.7 | 2.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.7 | 3.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
| 0.7 | 2.7 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.7 | 1.3 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.7 | 7.4 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
| 0.7 | 34.7 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.7 | 2.7 | GO:1902962 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.7 | 3.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.7 | 1.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.7 | 4.7 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.7 | 5.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.7 | 8.0 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.7 | 3.3 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.7 | 0.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.7 | 3.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
| 0.7 | 4.6 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
| 0.7 | 21.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.7 | 2.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.7 | 2.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.7 | 13.2 | GO:0007379 | segment specification(GO:0007379) |
| 0.7 | 2.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.7 | 9.9 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.7 | 2.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.7 | 9.2 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.7 | 3.3 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.7 | 4.6 | GO:1904550 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.7 | 3.9 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 0.7 | 1.3 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.7 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.7 | 3.9 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 | 41.1 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
| 0.7 | 2.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.6 | 0.6 | GO:0070668 | regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
| 0.6 | 7.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.6 | 0.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.6 | 2.6 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.6 | 1.3 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.6 | 8.4 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.6 | 1.9 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.6 | 8.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.6 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.6 | 8.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.6 | 7.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.6 | 0.6 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.6 | 5.1 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.6 | 8.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.6 | 7.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.6 | 5.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.6 | 3.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.6 | 0.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.6 | 1.9 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
| 0.6 | 1.9 | GO:0046850 | regulation of bone remodeling(GO:0046850) |
| 0.6 | 13.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.6 | 0.6 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.6 | 2.5 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.6 | 0.6 | GO:0050893 | sensory processing(GO:0050893) |
| 0.6 | 7.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.6 | 2.5 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.6 | 2.5 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) |
| 0.6 | 2.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.6 | 9.8 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.6 | 0.6 | GO:0044827 | modulation by host of viral process(GO:0044788) positive regulation by host of viral process(GO:0044794) modulation by host of viral genome replication(GO:0044827) |
| 0.6 | 2.4 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.6 | 3.7 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.6 | 6.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.6 | 6.7 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.6 | 6.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.6 | 7.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.6 | 2.4 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.6 | 3.0 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.6 | 10.8 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.6 | 1.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.6 | 14.9 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.6 | 1.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 1.8 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.6 | 1.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.6 | 2.4 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.6 | 3.6 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.6 | 4.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.6 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 0.6 | 4.1 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.6 | 3.5 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.6 | 12.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.6 | 1.2 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.6 | 6.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.6 | 1.2 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.6 | 0.6 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
| 0.6 | 2.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.6 | 2.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.6 | 2.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.6 | 1.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.6 | 1.7 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.6 | 2.8 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.6 | 5.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.6 | 0.6 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 | 5.1 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.6 | 2.3 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.6 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.6 | 12.9 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.6 | 1.1 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.6 | 0.6 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.6 | 7.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 | 2.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.6 | 1.7 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.6 | 1.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.6 | 6.1 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.6 | 2.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.6 | 1.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.6 | 6.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.6 | 0.6 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
| 0.6 | 1.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.6 | 6.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.6 | 8.8 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.5 | 4.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.5 | 3.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.5 | 2.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.5 | 4.9 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.5 | 1.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.5 | 1.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.5 | 2.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 | 6.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.5 | 1.6 | GO:0097066 | response to thyroid hormone(GO:0097066) |
| 0.5 | 2.7 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.5 | 1.6 | GO:0033341 | regulation of collagen binding(GO:0033341) |
| 0.5 | 25.4 | GO:0051225 | spindle assembly(GO:0051225) |
| 0.5 | 2.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.5 | 81.9 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.5 | 2.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
| 0.5 | 4.2 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.5 | 1.6 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.5 | 12.6 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.5 | 1.6 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.5 | 6.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.5 | 3.7 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 | 7.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.5 | 2.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.5 | 3.1 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
| 0.5 | 2.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.5 | 3.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.5 | 1.0 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.5 | 0.5 | GO:2000780 | negative regulation of double-strand break repair(GO:2000780) |
| 0.5 | 5.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.5 | 1.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.5 | 0.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.5 | 0.5 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.5 | 14.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.5 | 16.9 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.5 | 4.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.5 | 2.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.5 | 1.0 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.5 | 0.5 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
| 0.5 | 3.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.5 | 2.5 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.5 | 3.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.5 | 5.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.5 | 2.5 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.5 | 3.5 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.5 | 2.5 | GO:1903971 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 | 4.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.5 | 1.0 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.5 | 2.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.5 | 10.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.5 | 9.5 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.5 | 2.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 0.5 | 4.0 | GO:0042148 | strand invasion(GO:0042148) |
| 0.5 | 2.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.5 | 1.5 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
| 0.5 | 1.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.5 | 1.5 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.5 | 3.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.5 | 0.5 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 0.5 | 5.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.5 | 2.0 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.5 | 1.0 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.5 | 1.0 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.5 | 16.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.5 | 2.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.5 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.5 | 4.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.5 | 2.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.5 | 3.9 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.5 | 4.4 | GO:0043634 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.5 | 1.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.5 | 2.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.5 | 1.4 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 1.4 | GO:0060278 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.5 | 3.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.5 | 28.3 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.5 | 7.7 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
| 0.5 | 1.0 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 | 2.4 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.5 | 2.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.5 | 0.9 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
| 0.5 | 3.3 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.5 | 1.4 | GO:0018194 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.5 | 2.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.5 | 1.4 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.5 | 1.4 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.5 | 3.7 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.5 | 1.9 | GO:0035350 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
| 0.5 | 1.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.5 | 0.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.5 | 1.4 | GO:0033122 | regulation of cyclic nucleotide catabolic process(GO:0030805) negative regulation of cyclic nucleotide catabolic process(GO:0030806) regulation of cAMP catabolic process(GO:0030820) negative regulation of cAMP catabolic process(GO:0030821) regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
| 0.5 | 4.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.5 | 0.9 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.5 | 1.4 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.5 | 0.9 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.5 | 8.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.5 | 1.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
| 0.5 | 0.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.5 | 1.8 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.5 | 3.6 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.5 | 0.9 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.5 | 9.0 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.5 | 4.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 | 8.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.4 | 1.3 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.4 | 4.9 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
| 0.4 | 5.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.4 | 0.4 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.4 | 1.3 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.4 | 6.7 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.4 | 2.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 | 0.4 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
| 0.4 | 4.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.4 | 1.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.4 | 4.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.4 | 2.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 | 13.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.4 | 1.8 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.4 | 3.1 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.4 | 1.8 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.4 | 2.6 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.4 | 1.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.4 | 1.8 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.4 | 3.9 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 0.9 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.4 | 4.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.4 | 1.7 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.4 | 1.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.4 | 6.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.4 | 2.2 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.4 | 9.5 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.4 | 4.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 3.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.4 | 3.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.4 | 5.6 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.4 | 1.7 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.4 | 6.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.4 | 2.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.4 | 6.8 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 1.3 | GO:1903452 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.4 | 14.9 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 | 1.3 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.4 | 3.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.4 | 4.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.4 | 0.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.4 | 6.3 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.4 | 1.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.4 | 9.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
| 0.4 | 2.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 | 7.9 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.4 | 5.0 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.4 | 1.7 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 0.4 | 1.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 0.4 | 4.1 | GO:0014854 | response to inactivity(GO:0014854) |
| 0.4 | 2.5 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 | 2.9 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.4 | 7.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 1.6 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.4 | 0.4 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
| 0.4 | 1.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
| 0.4 | 3.3 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 | 0.8 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.4 | 0.8 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.4 | 6.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.4 | 2.0 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 | 3.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.4 | 1.6 | GO:0030473 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.4 | 1.6 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 0.8 | GO:0007135 | meiosis II(GO:0007135) |
| 0.4 | 1.6 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.4 | 1.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 0.4 | 1.2 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 | 0.4 | GO:0019563 | glycerol catabolic process(GO:0019563) |
| 0.4 | 1.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.4 | 5.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.4 | 0.4 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.4 | 2.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.4 | 0.4 | GO:0090427 | embryonic nail plate morphogenesis(GO:0035880) activation of meiosis(GO:0090427) |
| 0.4 | 1.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.4 | 6.2 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.4 | 2.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.4 | 0.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.4 | 6.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.4 | 2.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.4 | 2.7 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.4 | 3.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 1.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.4 | 0.8 | GO:1903516 | base-excision repair, DNA ligation(GO:0006288) regulation of single strand break repair(GO:1903516) regulation of DNA ligase activity(GO:1904875) |
| 0.4 | 11.9 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
| 0.4 | 0.4 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
| 0.4 | 0.4 | GO:0060157 | urinary bladder development(GO:0060157) |
| 0.4 | 11.8 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.4 | 1.1 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 0.4 | 9.8 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 | 1.9 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.4 | 1.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.4 | 7.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.4 | 1.1 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 | 2.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.4 | 4.5 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 0.4 | 1.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 0.4 | 1.5 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 0.4 | 1.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.4 | 1.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.4 | 1.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.4 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 | 7.8 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
| 0.4 | 2.6 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 0.4 | 2.6 | GO:0032869 | cellular response to insulin stimulus(GO:0032869) |
| 0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 | 5.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.4 | 1.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.4 | 3.0 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.4 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.4 | 13.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.4 | 11.4 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.4 | 3.3 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.4 | 5.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.4 | 0.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.4 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 | 0.4 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.4 | 3.2 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.4 | 11.1 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.4 | 9.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.4 | 1.1 | GO:1902166 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.4 | 1.4 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 0.4 | 2.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.4 | 0.7 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.4 | 1.1 | GO:0032328 | alanine transport(GO:0032328) |
| 0.4 | 1.4 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.4 | 3.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.4 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.4 | 13.0 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.4 | 1.8 | GO:0048565 | digestive tract development(GO:0048565) |
| 0.3 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.3 | 2.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.3 | 0.7 | GO:0006429 | leucyl-tRNA aminoacylation(GO:0006429) |
| 0.3 | 2.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.3 | 4.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.3 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.3 | 1.0 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.3 | 1.0 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.3 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.3 | 3.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.3 | 1.0 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 0.3 | 0.7 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.3 | 1.7 | GO:0034486 | vacuolar transmembrane transport(GO:0034486) late endosomal microautophagy(GO:0061738) chaperone-mediated protein transport involved in chaperone-mediated autophagy(GO:0061741) negative regulation of fibril organization(GO:1902904) chaperone-mediated autophagy translocation complex disassembly(GO:1904764) |
| 0.3 | 6.8 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.3 | 9.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 0.3 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.3 | 2.0 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.3 | 2.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 5.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.3 | 1.7 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.3 | 11.3 | GO:0046710 | GDP metabolic process(GO:0046710) |
| 0.3 | 1.3 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 | 2.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.3 | 6.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.3 | 1.7 | GO:0043473 | pigmentation(GO:0043473) |
| 0.3 | 1.3 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
| 0.3 | 2.0 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.3 | 4.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.3 | 0.3 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.3 | 0.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.3 | 1.0 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.3 | 23.6 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
| 0.3 | 5.9 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.3 | 0.3 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 | 6.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.3 | 1.3 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.3 | 0.3 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.3 | 7.8 | GO:0033622 | integrin activation(GO:0033622) |
| 0.3 | 1.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 2.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.3 | 0.6 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.3 | 0.6 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.3 | 2.2 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.3 | 0.9 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
| 0.3 | 2.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
| 0.3 | 0.6 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 | 3.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.3 | 6.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.3 | 4.4 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.3 | 0.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.3 | 3.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.3 | 4.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.3 | 0.9 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.3 | 1.6 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.3 | 0.3 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.3 | 0.6 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.3 | 5.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 3.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.3 | 4.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.3 | 0.3 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
| 0.3 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.3 | 1.5 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 | 1.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 | 1.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.3 | 8.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.3 | 0.9 | GO:0043201 | response to leucine(GO:0043201) |
| 0.3 | 0.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.3 | 2.7 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.3 | 6.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 0.3 | 9.7 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.3 | 0.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.3 | 3.0 | GO:0097435 | fibril organization(GO:0097435) |
| 0.3 | 2.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.3 | 0.3 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.3 | 0.9 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.3 | 2.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) protein transport into plasma membrane raft(GO:0044861) |
| 0.3 | 3.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.3 | 0.9 | GO:1901143 | insulin catabolic process(GO:1901143) |
| 0.3 | 1.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
| 0.3 | 2.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.3 | 0.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 18.8 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 0.6 | GO:0051466 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.3 | 1.5 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.3 | 11.0 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 | 0.9 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.3 | 4.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.3 | 5.9 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.3 | 5.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.3 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.3 | 5.0 | GO:0009650 | UV protection(GO:0009650) |
| 0.3 | 1.8 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.3 | 3.8 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.3 | 0.6 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 | 12.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.3 | 2.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.3 | 0.9 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.3 | 1.2 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.3 | 3.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.3 | 0.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.3 | 4.0 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.3 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 | 0.9 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 0.3 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.3 | 3.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
| 0.3 | 1.4 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.3 | 10.3 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
| 0.3 | 5.4 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.3 | 2.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
| 0.3 | 1.1 | GO:2000697 | negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
| 0.3 | 8.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.3 | 1.7 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.3 | 1.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 1.4 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.3 | 6.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.3 | 1.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.3 | 2.8 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.3 | 1.1 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
| 0.3 | 1.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.3 | 2.5 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.3 | 4.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.3 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.3 | 1.1 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
| 0.3 | 1.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.3 | 0.8 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.3 | 1.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.3 | 1.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.3 | 4.6 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.3 | 4.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.3 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.3 | 8.9 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.3 | 0.5 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
| 0.3 | 0.5 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.3 | 1.9 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.3 | 0.8 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.3 | 0.5 | GO:1903750 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.3 | 2.9 | GO:0051298 | centrosome duplication(GO:0051298) |
| 0.3 | 0.3 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 | 2.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 0.3 | 2.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 1.8 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 | 2.4 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 0.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.3 | 1.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.3 | 13.3 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
| 0.3 | 0.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.3 | 1.8 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.3 | 0.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.3 | 8.1 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.3 | 0.8 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
| 0.3 | 1.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.3 | 1.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 | 2.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.3 | 0.5 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.3 | 1.3 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.3 | 0.8 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
| 0.3 | 0.5 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.3 | 0.3 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.3 | 1.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.3 | 1.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
| 0.3 | 1.3 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.3 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.3 | 2.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.3 | 1.8 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.3 | 2.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 1.0 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.2 | 0.5 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 3.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.2 | 1.5 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.2 | 1.2 | GO:1990089 | response to nerve growth factor(GO:1990089) |
| 0.2 | 1.7 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.0 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.2 | 3.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
| 0.2 | 3.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.2 | 2.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 0.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.2 | 5.6 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.2 | 2.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.2 | 6.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.2 | 4.9 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 | 0.7 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 0.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 | 0.5 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.2 | 1.7 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 | 1.7 | GO:0048864 | stem cell development(GO:0048864) |
| 0.2 | 1.0 | GO:0030578 | PML body organization(GO:0030578) |
| 0.2 | 4.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 | 3.8 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
| 0.2 | 1.2 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.2 | 0.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.2 | 2.8 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 0.7 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.2 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 | 1.7 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.2 | 0.9 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.2 | 1.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.2 | 13.6 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.2 | 0.5 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 0.2 | 3.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 2.3 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.2 | 1.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.2 | 10.2 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 | 6.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 3.2 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.2 | 2.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.2 | 1.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 2.5 | GO:0016050 | vesicle organization(GO:0016050) |
| 0.2 | 4.1 | GO:0014002 | astrocyte development(GO:0014002) |
| 0.2 | 6.9 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
| 0.2 | 2.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.2 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.2 | 0.5 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
| 0.2 | 3.2 | GO:0035268 | protein mannosylation(GO:0035268) |
| 0.2 | 0.7 | GO:0035623 | renal glucose absorption(GO:0035623) |
| 0.2 | 1.6 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.2 | 1.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.2 | 1.6 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 0.9 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.2 | 0.7 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.2 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
| 0.2 | 1.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.2 | 2.0 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.2 | 3.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.2 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 0.7 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.2 | 0.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 | 1.6 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.2 | 1.8 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.2 | 10.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.2 | 2.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.2 | 2.0 | GO:0032743 | positive regulation of interleukin-2 production(GO:0032743) |
| 0.2 | 0.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
| 0.2 | 1.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 0.7 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 0.2 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 0.2 | GO:0009217 | purine deoxyribonucleotide catabolic process(GO:0009155) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
| 0.2 | 1.8 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.2 | 0.4 | GO:0060956 | cardiac endothelial cell differentiation(GO:0003348) endocardial cell differentiation(GO:0060956) |
| 0.2 | 0.9 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
| 0.2 | 2.4 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
| 0.2 | 2.4 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.2 | 4.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 1.3 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 0.2 | 0.6 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.2 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.2 | 0.6 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.2 | 2.6 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.2 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 3.4 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.2 | 0.4 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
| 0.2 | 1.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 0.4 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 | 0.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 0.4 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.2 | 1.5 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 3.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.2 | 0.6 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.2 | 2.3 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.2 | 1.7 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.2 | 2.1 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 1.5 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.2 | 1.0 | GO:0006404 | RNA import into nucleus(GO:0006404) snRNA import into nucleus(GO:0061015) |
| 0.2 | 1.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.2 | 1.2 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.2 | 8.6 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.2 | 1.0 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.2 | 2.2 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.2 | 0.6 | GO:0065001 | positive regulation of polarized epithelial cell differentiation(GO:0030862) specification of axis polarity(GO:0065001) |
| 0.2 | 2.0 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.2 | 0.2 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.2 | 1.0 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.2 | 3.8 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 1.0 | GO:0010828 | positive regulation of glucose transport(GO:0010828) positive regulation of glucose import(GO:0046326) |
| 0.2 | 0.8 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.2 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.2 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 0.2 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.2 | 1.6 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.2 | 1.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.2 | 2.8 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.2 | 1.2 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.2 | 0.2 | GO:1902749 | regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.2 | 2.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 1.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.2 | 1.0 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.2 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.2 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.2 | 1.0 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.2 | 18.1 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 1.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.2 | 0.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.2 | 0.6 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 0.2 | 1.0 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
| 0.2 | 1.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 | 1.9 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 0.2 | 0.8 | GO:1902914 | regulation of protein polyubiquitination(GO:1902914) |
| 0.2 | 0.8 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.2 | 0.6 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.2 | 0.8 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) |
| 0.2 | 0.2 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.2 | 0.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.2 | 0.2 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 0.8 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
| 0.2 | 17.1 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.2 | 2.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 1.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.4 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 0.2 | 0.9 | GO:0040034 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.2 | 6.9 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 | 2.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.2 | 1.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 1.3 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.2 | 3.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.2 | 2.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 0.6 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 | 0.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.2 | 0.9 | GO:0003383 | apical constriction(GO:0003383) |
| 0.2 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.2 | 0.2 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 0.2 | 1.6 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 0.2 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.2 | 2.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.2 | 1.8 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
| 0.2 | 7.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.2 | 1.6 | GO:0031960 | response to corticosteroid(GO:0031960) |
| 0.2 | 0.7 | GO:0051808 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.2 | 3.4 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.2 | 6.2 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
| 0.2 | 1.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.2 | 0.2 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.2 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.2 | 0.9 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
| 0.2 | 0.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 6.9 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.2 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.2 | 10.8 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
| 0.2 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.2 | 1.0 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 | 0.3 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
| 0.2 | 5.1 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.2 | 0.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 | 0.5 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.2 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
| 0.2 | 0.3 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.2 | 0.3 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.2 | 0.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.2 | 0.7 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.2 | 0.5 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 0.2 | 1.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.2 | 1.0 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.2 | 3.7 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.2 | 0.2 | GO:0045650 | negative regulation of granulocyte differentiation(GO:0030853) negative regulation of macrophage differentiation(GO:0045650) |
| 0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 1.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.2 | 1.8 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
| 0.2 | 0.8 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
| 0.2 | 1.4 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.2 | 0.9 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.2 | 1.4 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 3.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.2 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.2 | 1.7 | GO:0001553 | luteinization(GO:0001553) |
| 0.2 | 0.2 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.2 | 0.2 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.2 | 1.5 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
| 0.2 | 2.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.2 | 13.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.2 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.2 | 1.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 1.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 0.5 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.2 | 1.1 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.3 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
| 0.2 | 1.4 | GO:0014829 | vascular smooth muscle contraction(GO:0014829) |
| 0.2 | 0.3 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.2 | 0.8 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 | 0.9 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.1 | 1.2 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.6 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.1 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 0.9 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 2.5 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 3.2 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 0.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 0.1 | 0.1 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
| 0.1 | 1.6 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.1 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 2.4 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.1 | 0.7 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.1 | 1.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.1 | 1.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 | 0.9 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.1 | 3.6 | GO:0006101 | tricarboxylic acid cycle(GO:0006099) citrate metabolic process(GO:0006101) |
| 0.1 | 1.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 1.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.1 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.1 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 2.3 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.1 | 1.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 2.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.1 | 0.6 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 | 3.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
| 0.1 | 1.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 | 1.8 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 5.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.1 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 | 3.3 | GO:0033762 | response to glucagon(GO:0033762) |
| 0.1 | 0.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
| 0.1 | 1.5 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 | 0.3 | GO:0003231 | cardiac ventricle development(GO:0003231) |
| 0.1 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.1 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 9.8 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 3.6 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.1 | 0.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.1 | 2.0 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 4.1 | GO:1900739 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.1 | 0.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.1 | 3.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.1 | 0.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.1 | 0.5 | GO:0090094 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 | 1.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.1 | 1.2 | GO:0009415 | response to water(GO:0009415) |
| 0.1 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.1 | 2.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 2.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 0.5 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 1.0 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.1 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.1 | 0.4 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.1 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 | 0.6 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
| 0.1 | 0.4 | GO:1902579 | multi-organism transport(GO:0044766) multi-organism localization(GO:1902579) |
| 0.1 | 0.5 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.1 | 1.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.1 | 0.4 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 4.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 0.4 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.1 | 7.8 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 0.7 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.1 | 2.8 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.1 | 0.1 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
| 0.1 | 1.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.1 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 | 2.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.1 | 0.5 | GO:0071472 | cellular response to salt stress(GO:0071472) |
| 0.1 | 0.6 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.5 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 2.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 1.8 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.1 | 2.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.1 | 0.2 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
| 0.1 | 0.8 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.1 | 0.8 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.1 | 1.5 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.1 | 0.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.6 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 | 5.1 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.1 | 2.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.1 | 1.1 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
| 0.1 | 0.2 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.1 | 0.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.1 | 0.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.7 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 0.5 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 0.1 | 2.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 | 0.7 | GO:0018032 | protein amidation(GO:0018032) |
| 0.1 | 1.5 | GO:0044818 | mitotic G2/M transition checkpoint(GO:0044818) |
| 0.1 | 1.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.1 | 0.1 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.1 | 0.1 | GO:0070555 | response to interleukin-1(GO:0070555) |
| 0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 1.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.1 | 1.1 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.1 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
| 0.1 | 0.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.1 | 0.3 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
| 0.1 | 0.8 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
| 0.1 | 0.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 2.9 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.1 | 0.4 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
| 0.1 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 1.1 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 | 2.2 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 0.4 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.1 | 1.3 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.4 | GO:0042262 | DNA protection(GO:0042262) |
| 0.1 | 18.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
| 0.1 | 0.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.1 | 1.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.8 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.1 | 0.5 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
| 0.1 | 0.8 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 | 1.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 0.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
| 0.1 | 1.4 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.1 | 1.8 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.1 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.1 | 0.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.1 | 0.1 | GO:0001705 | ectoderm formation(GO:0001705) |
| 0.1 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.1 | 0.8 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 1.7 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.1 | 1.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 1.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.2 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 2.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.1 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 | 0.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 2.5 | GO:0051693 | actin filament capping(GO:0051693) |
| 0.1 | 0.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
| 0.1 | 0.3 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.1 | 0.3 | GO:0042113 | B cell activation(GO:0042113) |
| 0.1 | 1.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 | 2.4 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.1 | 1.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.1 | 0.2 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
| 0.1 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 | 0.2 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.1 | 1.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.4 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.1 | 0.4 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.1 | 0.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 | 0.1 | GO:0005997 | xylulose metabolic process(GO:0005997) |
| 0.1 | 9.1 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.1 | 0.3 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 | 1.0 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
| 0.1 | 18.3 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 | 1.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.1 | 0.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.1 | 1.3 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 | 3.1 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 0.1 | 0.5 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
| 0.1 | 0.4 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.2 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.1 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 2.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.1 | 0.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.1 | 4.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 0.2 | GO:0006304 | DNA modification(GO:0006304) |
| 0.1 | 0.4 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.6 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.1 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
| 0.1 | 0.1 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.1 | 0.1 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 0.1 | 0.2 | GO:0008406 | gonad development(GO:0008406) |
| 0.1 | 0.4 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.4 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.1 | 0.1 | GO:0019085 | early viral transcription(GO:0019085) |
| 0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.1 | 0.2 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
| 0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 1.7 | GO:0043039 | tRNA aminoacylation(GO:0043039) |
| 0.1 | 0.2 | GO:0002327 | immature B cell differentiation(GO:0002327) |
| 0.1 | 0.4 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 0.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.2 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 | 0.3 | GO:0001906 | cell killing(GO:0001906) |
| 0.1 | 0.2 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.1 | 0.9 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.1 | 1.2 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 | 0.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 0.1 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 | 0.1 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 | 0.1 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.1 | 0.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 0.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.1 | 0.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.3 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.1 | 0.1 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
| 0.1 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.1 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 | 0.9 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 3.4 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.1 | 0.9 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.1 | 0.1 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.1 | 0.1 | GO:0000819 | sister chromatid segregation(GO:0000819) |
| 0.1 | 0.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 7.0 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 0.3 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 | 0.5 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 1.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.1 | 1.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
| 0.1 | 0.2 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
| 0.1 | 1.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
| 0.1 | 0.8 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.1 | 0.9 | GO:0072348 | sulfur compound transport(GO:0072348) |
| 0.1 | 0.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.1 | 10.7 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 | 0.4 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 0.1 | 1.9 | GO:0022402 | cell cycle process(GO:0022402) |
| 0.1 | 0.2 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.1 | 0.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 | 1.9 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 0.3 | GO:0060147 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
| 0.1 | 3.5 | GO:0055072 | iron ion homeostasis(GO:0055072) |
| 0.1 | 0.6 | GO:0051608 | histamine transport(GO:0051608) |
| 0.1 | 1.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 0.6 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.1 | 0.7 | GO:0060074 | synapse maturation(GO:0060074) |
| 0.1 | 0.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.1 | 0.2 | GO:0006850 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.1 | 0.5 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.3 | GO:0016445 | somatic diversification of immunoglobulins(GO:0016445) |
| 0.1 | 2.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.1 | 1.0 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 0.6 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.1 | 2.7 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.1 | 0.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) cap-dependent translational initiation(GO:0002191) |
| 0.1 | 0.1 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.1 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.1 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.1 | 0.8 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 2.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.0 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 | 0.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 | 0.3 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
| 0.0 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
| 0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.0 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.0 | 0.2 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
| 0.0 | 0.5 | GO:0044598 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.0 | 0.1 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
| 0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
| 0.0 | 1.0 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
| 0.0 | 0.2 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.0 | 0.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
| 0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 | 0.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
| 0.0 | 0.2 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 0.5 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
| 0.0 | 0.2 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 | 0.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.4 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
| 0.0 | 0.5 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.0 | 0.3 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.0 | 0.0 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
| 0.0 | 0.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
| 0.0 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.0 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
| 0.0 | 0.6 | GO:0007625 | grooming behavior(GO:0007625) |
| 0.0 | 0.2 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
| 0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.0 | 0.2 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
| 0.0 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.0 | 0.1 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.0 | 0.6 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.1 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.0 | 0.1 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
| 0.0 | 0.6 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 0.5 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 | 0.1 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 0.0 | 0.4 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.2 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
| 0.0 | 0.0 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.0 | 0.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.8 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.0 | 0.3 | GO:0044782 | cilium organization(GO:0044782) |
| 0.0 | 1.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.3 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.0 | 0.3 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.0 | 0.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.0 | 0.2 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 | 1.0 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 5.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.7 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 | 0.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
| 0.0 | 0.1 | GO:0048536 | spleen development(GO:0048536) |
| 0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 1.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 0.5 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.0 | 0.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.2 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.0 | 0.1 | GO:0071048 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
| 0.0 | 0.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.0 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
| 0.0 | 0.1 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.0 | 0.1 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
| 0.0 | 1.0 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
| 0.0 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 0.0 | 0.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.0 | 0.1 | GO:0048145 | fibroblast proliferation(GO:0048144) regulation of fibroblast proliferation(GO:0048145) |
| 0.0 | 0.1 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.0 | 1.3 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.1 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
| 0.0 | 1.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.1 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.2 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.0 | 0.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.0 | 0.2 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 | 0.3 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 | 0.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.0 | 0.3 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 | 0.5 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.0 | 0.2 | GO:0045785 | positive regulation of cell adhesion(GO:0045785) |
| 0.0 | 0.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) |
| 0.0 | 0.2 | GO:0061001 | regulation of dendritic spine morphogenesis(GO:0061001) |
| 0.0 | 0.2 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.4 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.0 | 0.0 | GO:0007494 | midgut development(GO:0007494) |
| 0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
| 0.0 | 0.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.0 | 0.0 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.1 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.0 | 0.0 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 | 0.0 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.0 | 0.2 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.0 | 0.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.0 | 0.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.0 | 0.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.0 | 0.1 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.0 | 0.0 | GO:1904204 | skeletal muscle hypertrophy(GO:0014734) regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.0 | 0.1 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
| 0.0 | 0.1 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.0 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.0 | 0.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.0 | 0.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.0 | 0.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 | 0.0 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
| 0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.0 | 0.1 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.0 | 0.0 | GO:0002016 | regulation of blood volume by renin-angiotensin(GO:0002016) |
| 0.0 | 0.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 | 0.2 | GO:0009416 | response to light stimulus(GO:0009416) |
| 0.0 | 0.0 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.0 | 0.0 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.0 | 0.9 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
| 0.0 | 0.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
| 0.0 | 0.0 | GO:0070307 | lens fiber cell development(GO:0070307) |
| 0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.1 | GO:0009408 | response to heat(GO:0009408) |
| 0.0 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.0 | 0.1 | GO:0051604 | protein maturation(GO:0051604) |
| 0.0 | 0.0 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 0.0 | 0.2 | GO:0048477 | oogenesis(GO:0048477) |
| 0.0 | 0.0 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.0 | 0.8 | GO:0048515 | spermatid differentiation(GO:0048515) |
| 0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.0 | 0.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.0 | 0.1 | GO:0019541 | acetate metabolic process(GO:0006083) acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.0 | 0.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.0 | 0.3 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 8.0 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 2.6 | 13.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 2.6 | 10.3 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 2.5 | 20.3 | GO:0032437 | cuticular plate(GO:0032437) |
| 2.5 | 5.0 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 2.4 | 4.7 | GO:0097227 | sperm annulus(GO:0097227) |
| 2.2 | 6.6 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
| 2.2 | 13.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 2.1 | 6.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 2.0 | 8.1 | GO:0045160 | myosin I complex(GO:0045160) |
| 2.0 | 13.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 1.9 | 19.2 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 1.9 | 7.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 1.8 | 7.1 | GO:0000811 | GINS complex(GO:0000811) |
| 1.7 | 5.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 1.6 | 1.6 | GO:0030897 | HOPS complex(GO:0030897) |
| 1.6 | 6.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.6 | 1.6 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 1.6 | 12.5 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 1.6 | 6.2 | GO:0031523 | Myb complex(GO:0031523) |
| 1.5 | 4.6 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.5 | 10.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 1.5 | 4.4 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 1.4 | 8.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 1.4 | 7.0 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 1.4 | 4.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.3 | 8.0 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 1.3 | 6.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 1.3 | 5.3 | GO:0044753 | amphisome(GO:0044753) |
| 1.3 | 3.9 | GO:0075341 | host cell PML body(GO:0075341) |
| 1.3 | 2.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.2 | 9.7 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 1.2 | 3.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 1.2 | 8.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 1.2 | 3.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.1 | 10.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.1 | 9.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 1.1 | 5.5 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 1.1 | 3.3 | GO:0035101 | FACT complex(GO:0035101) |
| 1.1 | 9.7 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 1.1 | 3.2 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 1.1 | 4.3 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 1.1 | 7.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.1 | 3.2 | GO:0018444 | translation release factor complex(GO:0018444) |
| 1.0 | 14.5 | GO:0033269 | internode region of axon(GO:0033269) |
| 1.0 | 7.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.0 | 3.0 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 1.0 | 2.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) NatA complex(GO:0031415) |
| 1.0 | 18.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 1.0 | 3.0 | GO:0009346 | citrate lyase complex(GO:0009346) |
| 1.0 | 3.0 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 1.0 | 10.0 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 1.0 | 38.6 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 1.0 | 4.9 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 1.0 | 3.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.0 | 30.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 1.0 | 16.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 1.0 | 2.9 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.0 | 11.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 1.0 | 3.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.9 | 13.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.9 | 7.4 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.9 | 1.8 | GO:0044094 | viral replication complex(GO:0019034) host cell nuclear part(GO:0044094) |
| 0.9 | 11.1 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.9 | 14.7 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.9 | 4.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.9 | 2.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.9 | 2.7 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.9 | 5.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.9 | 3.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.9 | 2.6 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.9 | 9.5 | GO:0051286 | cell tip(GO:0051286) |
| 0.9 | 2.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.8 | 3.4 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.8 | 10.9 | GO:0042555 | MCM complex(GO:0042555) |
| 0.8 | 6.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.8 | 3.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.8 | 4.1 | GO:0032449 | CBM complex(GO:0032449) |
| 0.8 | 1.6 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.8 | 0.8 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.8 | 2.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.8 | 7.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.8 | 6.4 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.8 | 4.7 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.8 | 8.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.8 | 7.7 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.8 | 20.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.8 | 3.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.8 | 3.0 | GO:0043293 | apoptosome(GO:0043293) |
| 0.7 | 25.4 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.7 | 2.2 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.7 | 19.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.7 | 6.6 | GO:0045180 | basal cortex(GO:0045180) |
| 0.7 | 3.7 | GO:0071942 | XPC complex(GO:0071942) |
| 0.7 | 6.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.7 | 4.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.7 | 26.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.7 | 8.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.7 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.7 | 11.5 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.7 | 5.0 | GO:0000796 | condensin complex(GO:0000796) |
| 0.7 | 2.8 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.7 | 2.1 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.7 | 2.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.7 | 61.4 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.7 | 2.1 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.7 | 2.1 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.7 | 1.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.7 | 2.1 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 0.7 | 15.2 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.7 | 6.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.7 | 3.4 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.7 | 3.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.7 | 7.5 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.7 | 2.0 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.7 | 8.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.7 | 12.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.7 | 3.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.7 | 1.3 | GO:1990234 | transferase complex(GO:1990234) |
| 0.7 | 5.3 | GO:0030891 | VCB complex(GO:0030891) |
| 0.7 | 2.0 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.7 | 4.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.7 | 7.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.6 | 7.0 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.6 | 2.5 | GO:0001740 | Barr body(GO:0001740) |
| 0.6 | 21.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.6 | 5.7 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.6 | 11.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 3.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 0.6 | 2.5 | GO:0031251 | PAN complex(GO:0031251) |
| 0.6 | 9.2 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.6 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.6 | 14.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.6 | 10.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.6 | 15.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.6 | 3.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.6 | 7.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.6 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.6 | 1.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.6 | 3.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.6 | 8.2 | GO:0008091 | spectrin(GO:0008091) |
| 0.6 | 6.4 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.6 | 3.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.6 | 7.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.6 | 2.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.6 | 2.9 | GO:0044754 | autolysosome(GO:0044754) |
| 0.6 | 2.3 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.6 | 8.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.6 | 9.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.6 | 9.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.6 | 10.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.6 | 1.7 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.6 | 5.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.5 | 11.5 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.5 | 9.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.5 | 1.1 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.5 | 8.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.5 | 2.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.5 | 6.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.5 | 1.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.5 | 3.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.5 | 7.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.5 | 19.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.5 | 5.1 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.5 | 13.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.5 | 3.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.5 | 2.5 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.5 | 4.9 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.5 | 10.3 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.5 | 1.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.5 | 9.7 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.5 | 1.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.5 | 57.7 | GO:0005901 | caveola(GO:0005901) |
| 0.5 | 19.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.5 | 22.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.5 | 4.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.5 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.5 | 7.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.5 | 2.8 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.5 | 13.4 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.5 | 1.4 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.5 | 6.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.5 | 0.9 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.4 | 0.9 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
| 0.4 | 5.6 | GO:0090543 | Flemming body(GO:0090543) |
| 0.4 | 1.7 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.4 | 22.1 | GO:0032420 | stereocilium(GO:0032420) |
| 0.4 | 5.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.4 | 3.8 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.4 | 4.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.4 | 14.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 8.3 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.4 | 8.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 5.4 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.4 | 3.3 | GO:0033643 | host cell part(GO:0033643) |
| 0.4 | 0.8 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.4 | 3.2 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.4 | 3.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.4 | 12.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.4 | 0.4 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.4 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.4 | 2.8 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.4 | 11.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 1.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.4 | 1.6 | GO:0070419 | DNA ligase IV complex(GO:0032807) nonhomologous end joining complex(GO:0070419) |
| 0.4 | 1.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.4 | 8.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.4 | 8.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.4 | 13.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.4 | 3.0 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.4 | 3.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.4 | 1.9 | GO:0031417 | NatC complex(GO:0031417) |
| 0.4 | 1.5 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.4 | 0.8 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.4 | 1.1 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.4 | 8.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.4 | 1.5 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.4 | 27.8 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.4 | 3.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.4 | 11.0 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.4 | 61.0 | GO:0000922 | spindle pole(GO:0000922) |
| 0.4 | 8.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.4 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 2.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.4 | 3.6 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.4 | 1.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.4 | 1.4 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.4 | 34.7 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.3 | 10.0 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.3 | 11.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.3 | 12.1 | GO:0035861 | site of double-strand break(GO:0035861) |
| 0.3 | 11.4 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.3 | 1.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.3 | 9.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.3 | 4.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 4.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.3 | 1.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.3 | 1.3 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.3 | 19.5 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.3 | 3.7 | GO:0072487 | MSL complex(GO:0072487) |
| 0.3 | 22.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.3 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 2.0 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 7.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 2.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.3 | 2.0 | GO:0044308 | axonal spine(GO:0044308) |
| 0.3 | 11.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.3 | 5.2 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.3 | 1.9 | GO:0031673 | H zone(GO:0031673) |
| 0.3 | 52.9 | GO:0005884 | actin filament(GO:0005884) |
| 0.3 | 24.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.3 | 38.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.3 | 1.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 1.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.3 | 8.2 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.3 | 3.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 0.9 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 0.3 | GO:0043614 | multi-eIF complex(GO:0043614) |
| 0.3 | 2.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.3 | 2.2 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 15.9 | GO:0043034 | costamere(GO:0043034) |
| 0.3 | 0.3 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.3 | 9.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.3 | 1.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.3 | 1.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.3 | 1.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.3 | 3.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.3 | 2.0 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.3 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.3 | 0.3 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.3 | 3.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.3 | 1.4 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.3 | 19.5 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.3 | 2.0 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.3 | 2.8 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.3 | 6.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 2.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 0.6 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 6.7 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.3 | 17.8 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.3 | 3.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.3 | 1.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.3 | 1.6 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.3 | 0.8 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.3 | 18.7 | GO:0032155 | cell division site(GO:0032153) cell division site part(GO:0032155) |
| 0.3 | 1.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.3 | 1.1 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 2.9 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.3 | 23.8 | GO:0042641 | actomyosin(GO:0042641) |
| 0.3 | 0.8 | GO:0032838 | cell projection cytoplasm(GO:0032838) |
| 0.3 | 2.6 | GO:0033503 | HULC complex(GO:0033503) |
| 0.3 | 2.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 0.3 | GO:1990923 | PET complex(GO:1990923) |
| 0.3 | 0.8 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.3 | 3.4 | GO:0030175 | filopodium(GO:0030175) |
| 0.3 | 1.3 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.3 | 0.8 | GO:0097441 | basilar dendrite(GO:0097441) |
| 0.3 | 8.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.3 | 1.8 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.3 | 2.3 | GO:0005883 | neurofilament(GO:0005883) |
| 0.3 | 3.8 | GO:0038201 | TOR complex(GO:0038201) |
| 0.3 | 6.8 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 8.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.2 | 11.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 5.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.2 | 1.0 | GO:0060187 | cell pole(GO:0060187) |
| 0.2 | 0.5 | GO:0071203 | WASH complex(GO:0071203) |
| 0.2 | 1.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.2 | 1.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 0.7 | GO:0070993 | translation preinitiation complex(GO:0070993) |
| 0.2 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 3.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.2 | 2.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 2.2 | GO:0071437 | invadopodium(GO:0071437) |
| 0.2 | 8.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.2 | 10.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.2 | 19.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.2 | 36.4 | GO:0005819 | spindle(GO:0005819) |
| 0.2 | 16.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 1.0 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 2.1 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.2 | 2.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 18.5 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.2 | 1.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.2 | 1.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.2 | 0.7 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
| 0.2 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 8.1 | GO:0016592 | mediator complex(GO:0016592) |
| 0.2 | 16.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 5.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 12.8 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 1.1 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.2 | 4.1 | GO:0030904 | retromer complex(GO:0030904) |
| 0.2 | 5.4 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.2 | 21.0 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.2 | 4.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.2 | 24.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 0.8 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 5.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 1.7 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.2 | 2.5 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 0.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
| 0.2 | 1.4 | GO:0005912 | adherens junction(GO:0005912) |
| 0.2 | 6.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.2 | 0.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.2 | 16.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.2 | 1.0 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.2 | 0.4 | GO:0034657 | GID complex(GO:0034657) |
| 0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.2 | 3.6 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.2 | 2.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.6 | GO:0032783 | ELL-EAF complex(GO:0032783) |
| 0.2 | 5.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.2 | 4.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 0.6 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.2 | 17.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.2 | 2.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.2 | 1.5 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.2 | 1.3 | GO:0001652 | granular component(GO:0001652) |
| 0.2 | 1.5 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 0.7 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 0.2 | 1.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 1.4 | GO:0044440 | endosomal part(GO:0044440) |
| 0.2 | 2.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.2 | 44.8 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.2 | 21.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.2 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.2 | 6.8 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.2 | 1.0 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.2 | 0.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.2 | 0.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 28.1 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 1.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.2 | 1.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.2 | 3.5 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.2 | 0.3 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 1.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 18.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.2 | 0.7 | GO:1990745 | EARP complex(GO:1990745) |
| 0.2 | 0.6 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.2 | 6.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.2 | 0.5 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.2 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.2 | 10.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.1 | 1.5 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.1 | 0.9 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.1 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.1 | 3.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.1 | 2.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 2.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 4.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.1 | 4.8 | GO:0043657 | host(GO:0018995) host cell(GO:0043657) |
| 0.1 | 6.5 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.1 | 4.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 1.5 | GO:0019867 | outer membrane(GO:0019867) |
| 0.1 | 1.1 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.1 | 0.4 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.1 | 2.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.1 | 6.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 1.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.1 | 0.5 | GO:0031213 | RSF complex(GO:0031213) |
| 0.1 | 7.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 6.8 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.1 | 1.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.1 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.1 | 1.6 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 2.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 5.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 1.7 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 0.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 4.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.1 | 1.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 2.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.4 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 9.5 | GO:0031253 | cell projection membrane(GO:0031253) |
| 0.1 | 4.9 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.1 | 22.7 | GO:0098791 | Golgi subcompartment(GO:0098791) |
| 0.1 | 1.1 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.1 | 0.9 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 0.5 | GO:0098552 | side of membrane(GO:0098552) |
| 0.1 | 3.6 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.4 | GO:0097361 | CIA complex(GO:0097361) |
| 0.1 | 1.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.1 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 19.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 0.3 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 55.9 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.1 | 21.1 | GO:0005929 | cilium(GO:0005929) |
| 0.1 | 2.0 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 2.7 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.1 | 14.9 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.1 | 15.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 8.0 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 1.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 0.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.5 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 2.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 2.7 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.8 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.1 | 5.4 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.5 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.1 | 1.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 0.3 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.1 | 0.5 | GO:0097346 | INO80-type complex(GO:0097346) |
| 0.1 | 2.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 4.4 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.4 | GO:0043601 | nuclear replisome(GO:0043601) |
| 0.1 | 0.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.1 | 1.1 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 0.4 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.1 | 5.9 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 1.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 0.5 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
| 0.1 | 5.1 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 17.0 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 42.8 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 0.2 | GO:0032797 | SMN complex(GO:0032797) |
| 0.1 | 1.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 15.4 | GO:0005813 | centrosome(GO:0005813) |
| 0.1 | 4.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.1 | 8.6 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 12.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.1 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.1 | 33.8 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 0.4 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 1.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 1.5 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 2.1 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
| 0.1 | 1.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 0.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.1 | 1.4 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.8 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 1.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.1 | 13.2 | GO:0005874 | microtubule(GO:0005874) |
| 0.1 | 0.2 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 0.1 | 16.3 | GO:0005856 | cytoskeleton(GO:0005856) |
| 0.1 | 5.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
| 0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.3 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
| 0.1 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 0.3 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.0 | 218.4 | GO:0005829 | cytosol(GO:0005829) |
| 0.0 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.0 | 0.1 | GO:0005694 | chromosome(GO:0005694) |
| 0.0 | 2.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.1 | GO:0044327 | dendritic spine neck(GO:0044326) dendritic spine head(GO:0044327) |
| 0.0 | 6.0 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 0.1 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.0 | 37.4 | GO:0005654 | nucleoplasm(GO:0005654) |
| 0.0 | 0.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 1.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.0 | 0.1 | GO:0005903 | brush border(GO:0005903) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.0 | 24.3 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 3.9 | 19.7 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 3.5 | 10.4 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
| 3.4 | 30.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 3.2 | 12.9 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 3.0 | 9.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 2.9 | 11.4 | GO:0004325 | ferrochelatase activity(GO:0004325) |
| 2.7 | 13.6 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 2.6 | 10.3 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 2.6 | 7.7 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 2.4 | 7.3 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 2.4 | 2.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 2.3 | 9.1 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 2.2 | 19.9 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 2.0 | 6.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 2.0 | 8.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 2.0 | 10.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.9 | 7.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 1.9 | 11.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 1.9 | 7.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.8 | 7.4 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 1.8 | 7.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 1.8 | 5.3 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 1.7 | 5.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 1.7 | 5.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.7 | 10.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 1.7 | 8.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 1.7 | 5.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.7 | 15.5 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 1.7 | 5.1 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
| 1.7 | 10.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 1.7 | 5.1 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 1.7 | 8.3 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
| 1.7 | 6.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
| 1.6 | 9.8 | GO:0051870 | methotrexate binding(GO:0051870) |
| 1.6 | 11.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 1.6 | 17.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.6 | 7.8 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 1.6 | 12.5 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 1.6 | 4.7 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 1.5 | 6.2 | GO:0004803 | transposase activity(GO:0004803) |
| 1.5 | 3.0 | GO:0043398 | HLH domain binding(GO:0043398) |
| 1.5 | 4.4 | GO:0052830 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 1.5 | 1.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.4 | 4.3 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
| 1.4 | 1.4 | GO:0035877 | death effector domain binding(GO:0035877) |
| 1.4 | 9.8 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 1.4 | 5.6 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 1.4 | 5.4 | GO:0032427 | GBD domain binding(GO:0032427) |
| 1.4 | 32.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 1.4 | 10.9 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.3 | 6.7 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 1.3 | 4.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 1.3 | 4.0 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 1.3 | 4.0 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.3 | 2.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.3 | 4.0 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 1.3 | 3.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.3 | 9.0 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 1.3 | 6.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 1.3 | 10.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 1.3 | 5.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 1.2 | 3.7 | GO:0008478 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 1.2 | 3.7 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 1.2 | 9.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 1.2 | 50.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 1.2 | 13.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 1.2 | 11.0 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 1.2 | 1.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 1.2 | 14.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.2 | 3.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 1.2 | 32.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 1.2 | 9.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 1.2 | 1.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 1.1 | 4.5 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 1.1 | 6.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 1.1 | 5.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 1.1 | 3.3 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 1.1 | 6.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 1.1 | 4.4 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 1.1 | 5.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 1.1 | 4.3 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 1.1 | 8.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.1 | 3.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 1.1 | 11.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 1.1 | 5.4 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 1.1 | 1.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.1 | 3.2 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
| 1.1 | 4.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 1.1 | 4.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 1.0 | 3.1 | GO:0004513 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
| 1.0 | 4.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 1.0 | 4.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 1.0 | 8.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.0 | 8.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
| 1.0 | 5.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 1.0 | 3.0 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 1.0 | 3.0 | GO:0001147 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 1.0 | 3.0 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 1.0 | 12.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 1.0 | 1.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 1.0 | 4.9 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 1.0 | 7.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.0 | 2.9 | GO:0090541 | MIT domain binding(GO:0090541) |
| 1.0 | 2.9 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 1.0 | 4.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 1.0 | 10.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.9 | 2.8 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
| 0.9 | 4.7 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.9 | 2.8 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
| 0.9 | 13.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.9 | 4.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.9 | 12.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.9 | 2.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.9 | 2.8 | GO:0004818 | glutamate-tRNA ligase activity(GO:0004818) |
| 0.9 | 22.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.9 | 24.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.9 | 3.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.9 | 2.7 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.9 | 3.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.9 | 12.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.9 | 26.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.9 | 4.4 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.9 | 3.5 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 0.9 | 5.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.9 | 2.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.9 | 2.6 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.9 | 3.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.8 | 4.2 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.8 | 4.2 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.8 | 6.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.8 | 5.0 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.8 | 3.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.8 | 3.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.8 | 3.3 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.8 | 10.6 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.8 | 3.3 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.8 | 3.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.8 | 3.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.8 | 2.4 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
| 0.8 | 1.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.8 | 2.4 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
| 0.8 | 4.8 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
| 0.8 | 4.0 | GO:0070905 | serine binding(GO:0070905) |
| 0.8 | 8.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.8 | 7.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.8 | 18.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.8 | 6.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.8 | 11.7 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.8 | 7.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.8 | 16.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.8 | 3.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.8 | 2.3 | GO:0086039 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
| 0.8 | 11.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.8 | 5.4 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
| 0.8 | 9.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.8 | 1.5 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.8 | 9.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.8 | 12.8 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.8 | 7.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.7 | 3.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.7 | 2.2 | GO:0015067 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 0.7 | 3.0 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.7 | 4.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.7 | 5.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.7 | 2.9 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 0.7 | 6.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.7 | 5.9 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.7 | 5.8 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.7 | 2.2 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.7 | 15.2 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.7 | 11.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.7 | 7.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.7 | 2.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.7 | 10.5 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.7 | 6.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.7 | 2.1 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.7 | 3.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.7 | 21.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.7 | 19.9 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.7 | 2.7 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.7 | 2.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.7 | 2.0 | GO:0016826 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
| 0.7 | 4.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.7 | 4.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.7 | 2.7 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
| 0.7 | 2.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.7 | 4.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.7 | 9.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.7 | 1.3 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
| 0.7 | 2.0 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.7 | 2.0 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.7 | 2.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.7 | 3.9 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.7 | 1.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.7 | 2.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.6 | 5.8 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.6 | 1.9 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.6 | 6.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.6 | 8.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.6 | 12.7 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) |
| 0.6 | 3.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.6 | 5.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.6 | 5.7 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.6 | 2.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.6 | 2.5 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
| 0.6 | 3.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.6 | 4.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.6 | 3.7 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.6 | 6.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
| 0.6 | 6.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.6 | 1.8 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
| 0.6 | 6.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.6 | 4.8 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.6 | 3.6 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.6 | 19.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.6 | 3.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 0.6 | 2.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.6 | 3.5 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.6 | 6.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.6 | 10.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.6 | 2.9 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.6 | 4.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.6 | 2.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.6 | 2.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.6 | 1.7 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.6 | 2.3 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.6 | 8.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.6 | 2.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.6 | 1.7 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.6 | 2.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.6 | 1.7 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.6 | 1.7 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.6 | 3.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.6 | 5.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.6 | 1.7 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.6 | 4.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
| 0.6 | 6.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.6 | 3.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.6 | 1.1 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.6 | 1.7 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
| 0.6 | 8.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.5 | 8.2 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.5 | 3.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.5 | 19.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.5 | 15.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.5 | 2.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 4.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.5 | 4.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.5 | 1.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.5 | 1.6 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.5 | 2.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.5 | 2.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.5 | 2.1 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.5 | 7.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.5 | 2.6 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.5 | 1.6 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.5 | 0.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.5 | 2.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.5 | 3.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.5 | 3.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.5 | 9.3 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.5 | 4.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.5 | 25.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.5 | 4.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.5 | 3.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.5 | 2.5 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.5 | 2.0 | GO:0008483 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
| 0.5 | 3.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.5 | 5.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.5 | 15.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.5 | 1.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 7.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.5 | 1.0 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.5 | 1.5 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.5 | 9.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 18.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.5 | 1.9 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.5 | 1.5 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.5 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.5 | 6.8 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.5 | 3.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.5 | 1.4 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
| 0.5 | 2.4 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.5 | 4.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.5 | 1.0 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.5 | 1.9 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.5 | 4.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.5 | 1.9 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.5 | 3.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.5 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.5 | 1.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.5 | 1.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.5 | 0.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.5 | 1.9 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.5 | 17.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.5 | 3.3 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.5 | 2.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.5 | 1.9 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
| 0.5 | 1.4 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
| 0.5 | 0.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.5 | 1.8 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.5 | 2.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.5 | 1.4 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.5 | 1.4 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
| 0.5 | 1.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
| 0.5 | 2.7 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 3.2 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.4 | 3.1 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 1.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.4 | 9.8 | GO:0005112 | Notch binding(GO:0005112) |
| 0.4 | 9.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.4 | 1.8 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.4 | 17.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.4 | 6.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.4 | 5.6 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.4 | 1.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.4 | 0.4 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.4 | 3.5 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.4 | 1.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 1.7 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.4 | 7.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.4 | 3.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.4 | 4.3 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.4 | 1.7 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.4 | 2.1 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.4 | 1.3 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.4 | 9.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.4 | 1.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 0.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.4 | 3.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.4 | 26.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.4 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.4 | 0.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.4 | 14.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.4 | 14.9 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.4 | 2.1 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.4 | 2.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.4 | 3.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.4 | 1.2 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.4 | 1.2 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.4 | 2.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.4 | 4.1 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.4 | 4.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.4 | 0.8 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.4 | 2.0 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.4 | 9.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.4 | 1.2 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 0.4 | 6.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.4 | 6.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.4 | 10.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 7.5 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.4 | 23.0 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.4 | 1.2 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.4 | 0.8 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.4 | 14.6 | GO:0005521 | lamin binding(GO:0005521) |
| 0.4 | 1.2 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.4 | 3.1 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.4 | 0.8 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.4 | 0.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.4 | 3.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.4 | 13.5 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.4 | 3.5 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.4 | 28.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.4 | 4.6 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.4 | 0.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.4 | 85.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.4 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.4 | 2.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.4 | 1.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.4 | 1.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 34.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.4 | 1.9 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.4 | 1.1 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.4 | 6.7 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.4 | 11.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.4 | 2.2 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.4 | 2.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.4 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 2.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.4 | 2.2 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.4 | 19.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.4 | 4.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.4 | 1.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.4 | 2.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.4 | 1.1 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
| 0.4 | 1.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
| 0.4 | 1.1 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
| 0.4 | 4.3 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.4 | 2.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.4 | 10.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.4 | 1.4 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.4 | 1.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.4 | 2.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.4 | 2.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.4 | 7.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.4 | 1.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.3 | 1.4 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.3 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.3 | 2.8 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.3 | 14.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.3 | 1.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.3 | 92.8 | GO:0042393 | histone binding(GO:0042393) |
| 0.3 | 3.8 | GO:0034235 | GPI anchor binding(GO:0034235) glycolipid binding(GO:0051861) |
| 0.3 | 8.6 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.3 | 1.0 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.3 | 0.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.3 | 4.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.3 | 2.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.3 | 1.0 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.3 | 2.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.3 | 2.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 1.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.3 | 1.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.3 | 36.7 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.3 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.3 | 12.7 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.3 | 8.1 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.3 | 1.0 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.3 | 3.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.3 | 16.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.3 | 1.3 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
| 0.3 | 1.0 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.3 | 7.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.3 | 0.9 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
| 0.3 | 2.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 4.4 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.3 | 1.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.3 | 0.9 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.3 | 0.3 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 9.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 0.3 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.3 | 1.5 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.3 | 7.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.3 | 5.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.3 | 1.5 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.3 | 4.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.3 | 2.1 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.3 | 6.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.3 | 1.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.3 | 11.4 | GO:0043236 | laminin binding(GO:0043236) |
| 0.3 | 3.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.3 | 0.9 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.3 | 0.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.3 | 8.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.3 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.3 | 7.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 14.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
| 0.3 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.3 | 2.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.3 | 5.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 0.3 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.3 | 9.1 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.3 | 2.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 1.8 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.3 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
| 0.3 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
| 0.3 | 2.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.3 | 1.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.3 | 9.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.3 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.3 | 0.9 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 0.3 | 1.7 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.3 | 4.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 0.6 | GO:0032557 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) pyrimidine ribonucleotide binding(GO:0032557) |
| 0.3 | 2.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.3 | 0.3 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.3 | 2.0 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.3 | 1.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.3 | 2.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 0.3 | 6.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.3 | 12.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.3 | 1.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.3 | 0.3 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
| 0.3 | 0.8 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.3 | 2.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.3 | 10.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.3 | 24.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.3 | 28.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.3 | 0.3 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.3 | 1.9 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.3 | 5.5 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.3 | 2.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.3 | 0.8 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.3 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 3.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.3 | 1.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.3 | 4.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.3 | 1.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.3 | 3.7 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 5.8 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.3 | 0.5 | GO:0050661 | NADP binding(GO:0050661) |
| 0.3 | 0.8 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.3 | 3.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.3 | 4.8 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.3 | 10.3 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.3 | 1.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.3 | 3.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.3 | 1.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.3 | 2.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.3 | 0.8 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.3 | 0.8 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.3 | 3.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.3 | 0.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.3 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.3 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.3 | 0.8 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.3 | 14.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.3 | 126.8 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.3 | 2.5 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.3 | 2.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 0.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 5.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 0.3 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.2 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.5 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.2 | 1.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.2 | 0.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.2 | 8.4 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.2 | 9.1 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 1.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 6.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 0.5 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.2 | 1.2 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.2 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.2 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 1.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 34.3 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.2 | 3.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 3.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 11.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.2 | 0.7 | GO:0004823 | leucine-tRNA ligase activity(GO:0004823) |
| 0.2 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 5.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.2 | 1.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 0.2 | GO:0017111 | nucleoside-triphosphatase activity(GO:0017111) |
| 0.2 | 3.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 7.5 | GO:0004871 | signal transducer activity(GO:0004871) |
| 0.2 | 1.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.2 | 1.6 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 5.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.2 | 5.3 | GO:0005496 | steroid binding(GO:0005496) |
| 0.2 | 8.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 0.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 1.5 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.2 | 1.5 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.2 | 1.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.2 | 5.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.2 | 2.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 1.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 0.6 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.2 | 2.7 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.2 | 15.8 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.2 | 0.2 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 0.2 | 2.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.2 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 1.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.6 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.2 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 4.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 0.6 | GO:0016730 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.2 | 4.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.2 | 1.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.2 | 9.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.2 | 1.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.2 | 2.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.2 | 0.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.2 | 0.6 | GO:0016768 | spermine synthase activity(GO:0016768) |
| 0.2 | 5.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.2 | 0.6 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 1.6 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.2 | 1.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 1.0 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.2 | 1.0 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.2 | 9.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.2 | 0.8 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.2 | 44.9 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.2 | 6.5 | GO:0071617 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.2 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 5.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.2 | 0.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 1.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 3.9 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.2 | 4.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 1.7 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 10.7 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.2 | 6.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.2 | 0.7 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 6.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.2 | 2.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.2 | 0.7 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.2 | 1.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.2 | 5.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.2 | 1.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
| 0.2 | 0.5 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.2 | 0.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 1.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.2 | 1.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 3.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 4.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.2 | 0.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 10.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
| 0.2 | 12.0 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
| 0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.2 | 1.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.2 | 0.7 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.2 | 4.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 7.7 | GO:0031491 | nucleosome binding(GO:0031491) |
| 0.2 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.2 | 0.9 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 2.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 0.2 | 1.0 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.2 | 72.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 23.6 | GO:0004386 | helicase activity(GO:0004386) |
| 0.2 | 4.5 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.2 | 1.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.2 | 0.3 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 2.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
| 0.2 | 0.7 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.2 | 0.7 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.2 | 1.5 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.2 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.2 | 2.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 3.9 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
| 0.2 | 2.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.2 | 2.7 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 4.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 9.2 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.2 | 1.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 0.5 | GO:0004423 | iduronate-2-sulfatase activity(GO:0004423) |
| 0.2 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.2 | 0.9 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 3.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 16.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.2 | 3.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.2 | 0.2 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
| 0.2 | 1.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 0.5 | GO:0019825 | oxygen binding(GO:0019825) |
| 0.2 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.2 | 2.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.3 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 7.7 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 1.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 92.5 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.1 | 3.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.4 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.1 | 1.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 0.1 | 2.5 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.1 | 0.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 0.1 | 1.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 0.7 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.1 | 1.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.1 | 5.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 1.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.1 | 0.6 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 0.6 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.1 | 2.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 1.9 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.1 | 4.6 | GO:0017022 | myosin binding(GO:0017022) |
| 0.1 | 1.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 5.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 1.0 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 0.9 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.1 | 1.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.1 | 3.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.4 | GO:0047017 | prostaglandin-F synthase activity(GO:0047017) |
| 0.1 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.1 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 6.8 | GO:0051287 | NAD binding(GO:0051287) |
| 0.1 | 0.6 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
| 0.1 | 5.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 5.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.1 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.1 | 0.4 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.1 | 2.9 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.1 | 0.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.1 | 2.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 4.0 | GO:0101005 | ubiquitinyl hydrolase activity(GO:0101005) |
| 0.1 | 0.5 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 1.8 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.1 | 0.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 0.6 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.1 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 5.6 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.1 | 3.0 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.1 | 1.1 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 6.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.1 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.1 | 6.7 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.2 | GO:0016248 | ion channel inhibitor activity(GO:0008200) channel inhibitor activity(GO:0016248) |
| 0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 2.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 0.7 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
| 0.1 | 0.5 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 2.4 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
| 0.1 | 0.4 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.1 | 1.4 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.1 | 1.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 7.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.1 | 2.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 0.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.1 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
| 0.1 | 1.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 1.2 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.1 | 0.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 2.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 3.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.1 | 0.1 | GO:0052827 | inositol pentakisphosphate phosphatase activity(GO:0052827) |
| 0.1 | 0.3 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.1 | 0.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 0.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 0.1 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.1 | 1.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.1 | 12.2 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.1 | 0.2 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.1 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.1 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.1 | 2.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 1.2 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 0.7 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
| 0.1 | 0.4 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.1 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.4 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 24.1 | GO:0005525 | GTP binding(GO:0005525) |
| 0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.1 | 1.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 1.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.1 | 1.0 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 0.3 | GO:0000828 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) inositol hexakisphosphate kinase activity(GO:0000828) inositol heptakisphosphate kinase activity(GO:0000829) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.1 | 0.1 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.1 | 0.3 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 0.3 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.4 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.1 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.4 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
| 0.1 | 0.3 | GO:0016893 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016893) |
| 0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.1 | 0.2 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.1 | 0.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.1 | 1.4 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.1 | 0.2 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 0.1 | 1.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 3.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.1 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.1 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.1 | 0.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.9 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 0.4 | GO:0016301 | kinase activity(GO:0016301) |
| 0.1 | 0.2 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.1 | 0.9 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.1 | 0.2 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 0.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 0.1 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.0 | 1.1 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 2.0 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.0 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.0 | 9.5 | GO:0003779 | actin binding(GO:0003779) |
| 0.0 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 1.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 0.2 | GO:0003774 | motor activity(GO:0003774) |
| 0.0 | 0.2 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.0 | 0.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.0 | 1.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.2 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.0 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 1.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.0 | 0.8 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.0 | 0.0 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.5 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.0 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.0 | 0.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.0 | 1.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.0 | 0.6 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.0 | 0.0 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.0 | 0.2 | GO:0010736 | serum response element binding(GO:0010736) |
| 0.0 | 0.3 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.4 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
| 0.0 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.0 | 0.6 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
| 0.0 | 0.1 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
| 0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
| 0.0 | 0.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.0 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.0 | 4.5 | GO:0003713 | transcription coactivator activity(GO:0003713) |
| 0.0 | 0.1 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.0 | 0.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.0 | 0.0 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.1 | GO:0019201 | nucleotide kinase activity(GO:0019201) |
| 0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
| 0.0 | 0.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.0 | 0.1 | GO:0005113 | patched binding(GO:0005113) |
| 0.0 | 5.6 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
| 0.0 | 0.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.0 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
| 0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 0.0 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 0.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.0 | 0.0 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 0.0 | 0.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.0 | 1.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.0 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
| 0.0 | 0.0 | GO:0008892 | guanine deaminase activity(GO:0008892) |
| 0.0 | 0.8 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 1.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 2.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 1.0 | 47.5 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.9 | 26.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.9 | 64.0 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.9 | 68.9 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.8 | 71.4 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.7 | 36.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.7 | 20.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.7 | 44.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.7 | 22.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.7 | 6.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.7 | 3.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.6 | 47.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.6 | 1.9 | ST ADRENERGIC | Adrenergic Pathway |
| 0.6 | 53.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.6 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.6 | 39.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.6 | 57.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.5 | 7.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.5 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.5 | 19.7 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.5 | 24.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.5 | 0.9 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.5 | 16.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.5 | 42.4 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
| 0.4 | 24.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.4 | 30.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.4 | 12.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.4 | 4.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.4 | 3.0 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.4 | 16.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.4 | 3.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.4 | 24.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.4 | 14.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.4 | 16.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.4 | 5.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.4 | 52.1 | PID E2F PATHWAY | E2F transcription factor network |
| 0.4 | 12.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.4 | 16.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 2.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.3 | 4.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 5.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.3 | 5.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 17.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.3 | 17.9 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.3 | 10.8 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.3 | 8.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 1.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.3 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 16.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.3 | 4.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.3 | 6.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 1.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.2 | 16.9 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 8.7 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.2 | 0.7 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
| 0.2 | 3.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 12.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 7.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 1.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 27.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 6.7 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.2 | 4.8 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.2 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 4.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.2 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 8.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 10.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.2 | 0.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 2.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.2 | 13.1 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.2 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.2 | 14.0 | PID P73PATHWAY | p73 transcription factor network |
| 0.2 | 3.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 6.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 10.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.2 | 3.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 5.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.2 | 3.7 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.2 | 2.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.2 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.2 | 6.9 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.2 | 2.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.2 | 1.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 2.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 0.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 3.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 7.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 3.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 4.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.1 | 5.8 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 1.7 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.8 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 2.7 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 2.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 2.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.1 | 0.2 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 1.5 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.1 | 2.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 1.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 1.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.1 | 1.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 3.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 1.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 1.7 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
| 0.1 | 0.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.1 | 1.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 2.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.0 | 0.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 0.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.0 | 1.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.0 | 0.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.0 | 0.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 2.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 1.4 | 9.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 1.4 | 46.1 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 1.3 | 31.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.2 | 62.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 1.2 | 18.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.1 | 32.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 1.1 | 3.3 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 1.1 | 15.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 1.1 | 18.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 1.0 | 24.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.9 | 24.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.9 | 1.8 | REACTOME G PROTEIN BETA GAMMA SIGNALLING | Genes involved in G-protein beta:gamma signalling |
| 0.9 | 15.7 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.9 | 15.7 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.9 | 9.6 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.9 | 34.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.9 | 45.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.8 | 29.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.8 | 6.1 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.7 | 9.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.7 | 35.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.7 | 109.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.7 | 13.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.7 | 7.5 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.7 | 16.3 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.7 | 30.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.7 | 18.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.7 | 7.9 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.7 | 26.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.7 | 28.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.6 | 27.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 0.6 | 5.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.6 | 1.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
| 0.6 | 22.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.6 | 3.7 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 0.6 | 14.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.6 | 52.1 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.6 | 11.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.6 | 8.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.6 | 7.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.5 | 6.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.5 | 5.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.5 | 4.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.5 | 32.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.5 | 4.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.5 | 4.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.5 | 14.5 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.5 | 25.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.5 | 2.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.5 | 11.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 20.0 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.5 | 17.1 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.5 | 4.7 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.5 | 19.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.5 | 14.5 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.5 | 12.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.5 | 2.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.4 | 0.9 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.4 | 8.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.4 | 16.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.4 | 9.8 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.4 | 42.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.4 | 8.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.4 | 12.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.4 | 11.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.4 | 2.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.4 | 18.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.4 | 14.1 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.4 | 4.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.4 | 7.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.4 | 1.9 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.4 | 8.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.4 | 15.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.4 | 5.6 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.4 | 4.9 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.4 | 25.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.4 | 11.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.4 | 35.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.4 | 20.7 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.4 | 8.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 11.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.4 | 15.0 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.4 | 3.9 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.4 | 3.2 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
| 0.3 | 3.1 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.3 | 6.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.3 | 13.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.3 | 8.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 12.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.3 | 11.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.3 | 8.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.3 | 2.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.3 | 4.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 8.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.3 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.3 | 4.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.3 | 9.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.3 | 0.3 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
| 0.3 | 1.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 0.3 | 11.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.3 | 2.7 | REACTOME OPSINS | Genes involved in Opsins |
| 0.3 | 4.8 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.3 | 4.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 20.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.3 | 1.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.3 | 9.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 2.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.3 | 6.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.3 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.3 | 1.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.3 | 3.4 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.3 | 7.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.3 | 1.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.3 | 8.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.3 | 5.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.3 | 11.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.3 | 5.9 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.3 | 5.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.3 | 5.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.3 | 2.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.3 | 16.8 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.3 | 4.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.3 | 1.5 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 3.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.3 | 9.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 8.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 7.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 14.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 2.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.2 | 5.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 3.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.2 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 8.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.2 | 16.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.2 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.2 | 11.2 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.2 | 3.4 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.2 | 4.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 11.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 3.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.2 | 4.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.2 | 0.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 2.9 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.2 | 12.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.2 | 1.2 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 0.2 | 1.8 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 0.2 | 1.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.2 | 11.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.2 | 2.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.2 | 23.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.2 | 0.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.2 | 13.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.2 | 2.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.2 | 2.5 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.2 | 8.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 9.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.2 | 1.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 2.7 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.2 | 1.8 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 0.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
| 0.1 | 42.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 1.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 1.4 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 2.5 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.1 | 7.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 1.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.1 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.1 | 4.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 3.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.1 | 10.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.1 | 4.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 20.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 2.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 6.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 0.1 | 5.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.1 | REACTOME S PHASE | Genes involved in S Phase |
| 0.1 | 5.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 3.5 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
| 0.1 | 2.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 0.5 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 3.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 4.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.1 | 1.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.1 | 8.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 1.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.1 | 1.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 2.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.1 | 2.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.2 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 5.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 1.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.1 | 0.1 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.1 | 0.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.1 | 1.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 0.8 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.1 | 1.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.1 | 6.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.0 | 3.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 1.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 1.1 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.0 | 0.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.0 | 0.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 0.4 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |